Maternal Immunization: Protected Together

Pregnant Woman leaning against the wall

Maternal immunization is a promising strategy for protecting mothers, the developing fetus, and young infants during a particularly vulnerable time in their lives – especially in low- and middle-income countries where morbidity and mortality among women and their children is high. During pregnancy, vaccines allow antibodies from the mother to cross into the placenta, protecting moms and their babies from life-threatening illnesses.

Key Messages

  1. Maternal immunization is an important strategy for protecting infants and newborns in the vulnerable period before they can receive their own vaccinations.
  2. Providing high-value antenatal care (ANC) during pregnancy can include vaccination against diseases like influenza, pertussis, and tetanus—which can help set both mother and baby up to survive and thrive.
  3. Complications from vaccine-preventable infections during pregnancy and early infancy can have cascading health and economic effects on individuals, families, communities, and health systems.
  4. Maternal immunization offers a critical opportunity to elevate maternal and newborn health on the broader health and development agenda and catalyze progress toward Sustainable Development Goal (SDG) 3.

Maternal Immunization: The Window of Vulnerability

Because newborn babies are too young to receive most vaccines, they are unprotected against many pathogens that can cause severe infections leading to hospitalization, long-term health problems, or death. Maternal immunization provides an important opportunity to protect the unborn child, the newborn, and in many cases, the mother, from preventable illnesses.

Providing vaccines during pregnancy not only boosts the mother’s immunity against dangerous pathogens, but a mother’s antibodies can be passed to her unborn baby in-utero through the placenta or through breast milk. For newborn babies, these maternal antibodies provide essential protection during a “window of vulnerability” when infants are too young to get their own immunizations.

Lackritz EM, Stepanchak M, Stergachis A. Maternal immunization safety monitoring in low- and middle-income countries: a roadmap for program development. Bill & Melinda Gates Foundation and Global Alliance to Prevent Prematurity and Stillbirth (GAPPS), 2017.

The Neonatal Period is Critical for Child Survival

Even one preventable child death is too many. Analysis by the WHO shows that the first 28 days of life for a baby – also called the neonatal period – is when a child’s survival is most threatened. Based on 2018 estimates, around 2.5 million neonates die in their first month of life, annually around the world.

2015 report from the Bill and Melinda Gates Foundation assessed opportunities for maternal immunization in resource-limited settings, estimating that more than half of neonatal deaths in the first month of life are associated with infections (22%). When that infection is vaccine-preventable, maternal immunization can help protect mothers, the unborn fetus, and infants during this vulnerable window.

Child mortality rates have fallen dramatically, but the progress has not been even across all child ages 

Maternal Immunization Can Prevent Severe, Costly Adverse Health Outcomes

Several studies have found that pregnant women and infants under 6 months are at increased risk of severe illness from infectious diseases such as influenza and pertussis that can lead to hospitalization or admission to intensive care units.

  • In a large U.S. study1, infants born to mothers who reported receiving influenza vaccination during pregnancy had an 81% lower chance of being hospitalized with influenza compared to infants whose mothers did not receive influenza immunization.
  • A 2017 study2 in the U.S. found that vaccinating women with Tdap during the third trimester of pregnancy provided 81% protection against pertussis to infants <2 months and 91% protection against hospitalization for pertussis.
  • A 2018 analysis3 of data from Nepal, Mali, and South Africa found evidence that maternal influenza immunization may reduce severe pneumonia episodes among infants <6 months. Overall, the incidence rate of severe pneumonia was 20% lower in infants in the maternal immunization group compared with the control group, although this rate varied by country.

Strengthening Maternal and Child Health Equity

Globally, 2017 data show that over 800 women die every day due to preventable causes related to pregnancy and childbirth. These deaths are inequitably distributed: the vast majority of maternal deaths (94%) occur in low-resource settings and overwhelmingly impact the poorest and most vulnerable populations, communities of women and children with the most limited access to routine health care.

Many of the same barriers that prevent women from receiving or seeking care during pregnancy and childbirth are the same barriers that prevent their children from accessing life-saving vaccinations:

  • Poverty
  • Distance to facilities
  • Lack of information
  • Inadequate and poor-quality services
  • Cultural beliefs and practices
https://data.unicef.org/topic/child-survival/neonatal-mortality/

Immunization as a Gateway to Maternal Health Services

Since it was established in 1974, the Expanded Program on Immunization (EPI) now reaches 85% of children globally with life-saving vaccines. With its strong service delivery infrastructure, immunization can provide a gateway to help connect women and their families with additional health services. A 2019 WHO Maternal Immunization and Antenatal Care Situation Analysis (MIACSA) Project report suggests that integration of immunization with other antenatal services is a promising strategy that can lead to “increased coverage, improved system efficiency, improved user satisfaction and increased demand.”

EPI’s strong delivery system has the potential to integrate additional reproductive, maternal, neonatal, and child health interventions with immunization. A 2013 knowledge summary describes how with thoughtful and measured planning, non-vaccine health interventions can be integrated with immunization visits to create a “programme foundation through which broad services can be equitably provided as well as give a beneficial boost to EPI coverage.”

Mothers who Use Maternal Health Services are More Likely to Have Fully Immunized Children

UNICEF reports that an estimated 86% of pregnant women globally have some form of antenatal care contact with a skilled health provider at least once in their pregnancy. However, current WHO guidance is that women receive eight or more contacts for antenatal care over the course of a pregnancy. For many women, particularly those in LMICs, pregnancy may be the first time a woman has contact with formal health services. Several studies across different countries have found that access to maternal health services is also associated with higher rates of immunization in children.

  • In Pakistan4, women who had 3 or 4 antenatal care contacts had children who were 40-60% more likely to receive all required vaccines on time compared to children whose mothers made only 1 or 2 ANC visits.
  • 2019 Nigerian study5 found that ANC attendance, skilled birth attendance, and postnatal care were significantly associated with a woman’s child being fully immunized irrespective of socio-economic status, geopolitical zone, place of residence, parity, person who decides on mother’s healthcare and mother’s age. This finding is consistent with studies in Senegal, Bangladesh, Indonesia, India, and Zimbabwe, which showed that a mother’s ANC attendance was significantly associated with full immunization of her children.
  • 2019 study6 of basic vaccine coverage of children in Myanmar found that those born to mothers who received tetanus vaccination during pregnancy were three times more likely to have completed their recommended vaccinations by age two compared to children of mothers who did not receive tetanus toxoid vaccination.

The Maternal Neonatal Tetanus Elimination program has been cited as proof of concept for the feasibility and potential for maternal immunization to reduce neonatal mortality particularly in LMICs (Krishnaswamy, S., Lambach, P., & Giles, M. L., 2019)

A Good Investment: Cost-effectiveness of Maternal Immunization

The cost-effectiveness of different maternal immunization strategies varies by country, context, and health priorities. Several studies examining the cost-effectiveness of maternal immunization have found that it can be cost-effective, depending on a variety of factors.

  • Brazil has experienced a significant increase in pertussis incidence since 2011 which has particularly affected infants <4 months of age. A 2016 cost-effectiveness analysis7 found that introducing universal maternal vaccination with Tdap into the National Immunization Program in Brazil could be a cost-effective intervention. However, a 2020 cost-effectiveness analysis8 concluded that universal adult immunization of Tdap would not be cost-effective.
  • Several analyses in high-income countries have found that maternal immunization for pertussis can be cost-effective. A 2018 study9 in Japan concluded cost-effectiveness could be reached even if only 50% of pregnant women received the vaccine. A 2016 study10 in the United States suggests that maternal immunization for pertussis is cost-effective compared to other adult vaccination strategies for preventing infection in infants too young to be vaccinated (postpartum vaccination, vaccination of a second parent, or untargeted vaccination of comparably aged adults).
  • 2016 analysis11 estimated that in Mozambique almost 18,000 neonatal tetanus cases could be prevented annually if pregnant women had better geographic access to a health facility offering tetanus toxoid vaccine. Reducing vaccine-preventable cases of neonatal tetanus could save the country an estimated $183,931,229–$522,248,480 in annual treatment costs and productivity losses.

The Future of Maternal Immunization

There are promising new maternal vaccines in development for two major causes of infant deaths that disproportionately impact those living in LMICs: Group B streptococcus (GBS) and respiratory syncytial disease (RSV).

Group B Streptococcus is a bacterial infection that causes an estimated 150,000 preventable stillbirths and infant deaths worldwide every year. A 2017 journal article12 estimates that GBS “is an important component of the worldwide burden of 2.6 million stillbirths,” accounting for an estimated 4% of stillbirths in sub-Saharan Africa. No licensed vaccines currently exist against GBS, but work is underway to develop a vaccine that can be given to pregnant women so that newborns are protected even before birth.

RSV can be deadly for infants, particularly those living in LMICs. It’s estimated that RSV causes 1.4 million hospitalizations in the first 6 months of life and 120,000 deaths before five years of age worldwide each year. Currently, the treatments available for RSV are limited but several vaccines are in development.

References

  1. Shakib, J. H., Korgenski, K., Presson, A. P., Sheng, X., Varner, M. W., Pavia, A. T., & Byington, C. L. (2016). Influenza in infants born to women vaccinated during pregnancy. Pediatrics137(6). https://doi.org/10.1542/peds.2015-2360
  2. Skoff, T. H., Blain, A. E., Watt, J., Scherzinger, K., McMahon, M., Zansky, S. M., Kudish, K., Cieslak, P. R., Lewis, M., Shang, N., & Martin, S. W. (2017). Impact of the us maternal tetanus, diphtheria, and acellular pertussis vaccination program on preventing pertussis in infants <2 months of age: A case-control evaluation. Clinical Infectious Diseases65(12), 1977–1983. https://doi.org/10.1093/cid/cix724
  3. Omer, S. B., Clark, D. R., Aqil, A. R., Tapia, M. D., Nunes, M. C., Kozuki, N., Steinhoff, M. C., Madhi, S. A., Wairagkar, N., & for BMGF Supported Maternal Influenza Immunization Trials Investigators Group. (2018). Maternal influenza immunization and prevention of severe clinical pneumonia in young infants: Analysis of randomized controlled trials conducted in Nepal, Mali and South Africa. The Pediatric Infectious Disease Journal37(5), 436–440. https://doi.org/10.1097/INF.0000000000001914
  4. Noh, J.-W., Kim, Y., Akram, N., Yoo, K.-B., Park, J., Cheon, J., Kwon, Y. D., & Stekelenburg, J. (2018). Factors affecting complete and timely childhood immunization coverage in Sindh, Pakistan; A secondary analysis of cross-sectional survey data. PLOS ONE13(10), e0206766. https://doi.org/10.1371/journal.pone.0206766
  5. Anichukwu, O. I., & Asamoah, B. O. (2019). The impact of maternal health care utilisation on routine immunisation coverage of children in Nigeria: A cross-sectional study. BMJ Open9(6), e026324. https://doi.org/10.1136/bmjopen-2018-026324
  6. Nozaki, I., Hachiya, M., & Kitamura, T. (2019). Factors influencing basic vaccination coverage in Myanmar: Secondary analysis of 2015 Myanmar demographic and health survey data. BMC Public Health19(1), 242. https://doi.org/10.1186/s12889-019-6548-0
  7. Sartori, A. M. C., de Soárez, P. C., Fernandes, E. G., Gryninger, L. C. F., Viscondi, J. Y. K., & Novaes, H. M. D. (2016). Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil. Vaccine34(13), 1531–1539. https://doi.org/10.1016/j.vaccine.2016.02.026
  8. Fernandes, E. G., Sartori, A. M. C., de Soárez, P. C., Amaku, M., de Azevedo Neto, R. S., & Novaes, H. M. D. (2020). Cost-effectiveness analysis of universal adult immunization with tetanus-diphtheria-acellular pertussis vaccine (Tdap) versus current practice in Brazil. Vaccine38(1), 46–53. https://doi.org/10.1016/j.vaccine.2019.09.100
  9. Hoshi, S., Seposo, X., Okubo, I., & Kondo, M. (2018). Cost-effectiveness analysis of pertussis vaccination during pregnancy in Japan. Vaccine36(34), 5133–5140. https://doi.org/10.1016/j.vaccine.2018.07.026
  10. Atkins, K. E., Fitzpatrick, M. C., Galvani, A. P., & Townsend, J. P. (2016). Cost-Effectiveness of Pertussis Vaccination During Pregnancy in the United States. American Journal of Epidemiology183(12), 1159–1170. https://doi.org/10.1093/aje/kwv347
  11. Haidari, L. A., Brown, S. T., Constenla, D., Zenkov, E., Ferguson, M., de Broucker, G., Ozawa, S., Clark, S., & Lee, B. Y. (2016). The economic value of increasing geospatial access to tetanus toxoid immunization in Mozambique. Vaccine34(35), 4161–4165. https://doi.org/10.1016/j.vaccine.2016.06.065
  12. Seale, Anna C, Hannah Blencowe, Fiorella Bianchi-Jassir, Nicholas Embleton, Quique Bassat, Jaume Ordi, Clara Menéndez, et al. “Stillbirth with Group b Streptococcus Disease Worldwide: Systematic Review and Meta-Analyses.” Clinical Infectious Diseases 65, no. suppl_2 (November 6, 2017): S125–32. https://doi.org/10.1093/cid/cix585.

Possibilities: The Far-Reaching Benefits of Immunization

Nurse preparing Immunization

The story of immunization is often headlined with the remarkable health benefits—millions of lives saved, and illnesses and hospitalizations prevented. But the true impact of vaccination is even more far-reaching, touching many areas of people’s lives from supporting early childhood growth and development to improving educational outcomes and productivity, promoting economic stability, and helping to address equity gaps: It’s seemingly impossible to undersell the importance of vaccination.

This World Immunization Week, the VoICE editors highlight some of the broader benefits of immunization—not only helping to prevent illness and save lives, but also promoting healthy development, productivity, economic stability, and equity for all.

Key Messages

  1. Only looking at the direct impact of vaccination on morbidity and mortality grossly underestimates the wider value of vaccination on overall health and development
  2. Several studies show that immunization has the potential to increase productivity by averting preventable illness
  3. Vaccines are associated with improved cognitive ability, education, and healthy physical development – which translates into increased economic productivity
  4. Vaccine-preventable diseases disproportionately affect the poorest children and families, but immunization can be a cost-effective tool to improve equity across geographies, gender, and marginalized populations

Preventing Pandemics Supports Economic Stability

The global health community is now facing an unprecedented challenge in the COVID-19 pandemic. As countries across the world attempt to slow the virus’s spread, this event has become a potent reminder of the vital importance of vaccination; we are seeing today just how much an infectious disease outbreak can ravage both national and global economies. Vaccines are important tools to help avert potentially catastrophic health costs that arise from preventable infectious disease outbreaks. Several studies have found that vaccines can bring additional stability to national economies by preventing the high costs incurred by illnesses.

  • 2009 study in Africa found an economic loss of US $43-72 million resulting from the 110,837 cases of cholera reported in 20071.
  • Researchers modeling the costs of potential pandemic influenza in the UK estimated costs of illness between £8.4 and £72.3 billion depending on the severity of the fatality rate, and even larger still for an extreme pandemic. In such a scenario, vaccination could limit the overall economic impact of pandemics2.
Quote

Vaccines Help Promote Productivity

 Productivity—the measure of output by a working individual or a population—is an important determinant of standard of living. By preventing illness, vaccination can help promote productivity by supporting healthy cognitive development and success in school, ultimately helping children achieve their full potential across the lifespan.

  • 2019 longitudinal study followed almost 6,000 children in India, Ethiopia, and Vietnam throughout childhood, finding that those vaccinated against measles scored better on cognitive tests of language development, math, and reading compared to children who did not receive measles vaccines3.
  • In a 2011 study in the Philippines, children vaccinated against six diseases performed significantly better on verbal reasoning, math and language tests than unvaccinated children4.
  • Vaccine-preventable diseases lead to both work and school absenteeism, which can negatively impact productivity and cause a substantial economic burden. A Norwegian study found that children hospitalized with rotavirus were absent from daycare for 6.3 days, on average, and 73% of their parents missed work5.

Vaccines Support Healthy Child Growth and Development

Some vaccine-preventable diseases can delay or interrupt normal growth and development in early childhood, leading to long-lasting damage that can adversely impact children for the rest of their lives. Persistent or recurrent infections in early life can lead to poor growth and stunting, which in turn can adversely affect adult health, cognitive capacity, and economic productivity.

  • Childhood vaccination programs can be a tool for mitigating undernutrition in developing countries. Children enrolled in Universal Immunization Programs observe improvements in terms of age-appropriate height and weight as per results of a study focused on 4-year-old children in India. On average, height and weight deficits were reduced by 22-25% and 15% respectively6.
  • study in Kenya revealed that polio, BCG, DPT and measles immunization had protective effects with respect to stunting in children. In children under the age of 2 years, children immunized with polio, BCG, DPT, and measles vaccines were 27% less likely to experience stunting compared to unimmunized children7.
  • A 2013 study conducted in several developing countries found that children with moderate-to-severe diarrhea grew significantly less in length in the two months following an episode of illness compared to age- and gender-matched controls8.
  • Modeling of data from India’s 2005-2006 National Family Health Survey indicated that vaccinations against DPT, polio, and measles were significant positive predictors of a child’s height, weight, and hemoglobin concentration. Such indicators, in turn, influence children’s cognitive development and hence the future supply of skilled labor that is critical for economic growth9.

Tackling Immunization Inequities Can Have Substantial Benefits

While huge progress has been made in introducing and scaling up access to important vaccines, we still have a long way to go. There is significant evidence of inequities in vaccine coverage that exists between and within countries, as well as between and within different populations. In Gavi-supported countries, there are still an estimated 10.4 million “zero-dose children” who have not received any doses of DTP-containing vaccine.

  • Results of a 2019 study in Kenya found that immunization outreach for remote or hard-to-reach populations can still be highly cost-effective. The study found that failure to vaccinate hard-to-reach children against measles would result in more than 1,400 measles cases, 257 deaths, and cost nearly U.S. $10 million over the course of 4 years, mainly due to productivity losses from caretakers missing work10.
  • 2018 study found that children of poor labor migrants living in Delhi, India are much less likely to be fully vaccinated than the general population and thus are at greater risk of vaccine-preventable diseases. Only 31% – 53% of children from migrant families were fully immunized (against 7 diseases) by 12 months of age, compared to 72% in the overall population of Delhi — with recent migrants having the lowest rates11.
  • Researchers looking at vaccination coverage in 45 low- and middle-income countries found that maternal education is a strong predictor of vaccine coverage. Children of the least educated mothers are 55% less likely to have received measles-containing vaccine and three doses of DTP vaccine than children of the most educated mothers12.

The evidence shows that vaccines offer cross-cutting benefits for individuals, families, communities, and truly everyone across the globe. Cross-disciplinary research from many global health perspectives demonstrates that vaccines as a versatile, impactful tool that does so much more than just preventing millions of deaths and illness every year: Vaccines benefit global economies, boost productivity, and help close gaps in equity.

As we respond to COVID-19, the reality that infectious disease outbreaks anywhere in the world can quickly become a threat anywhere further highlights the importance of investment in vaccination as a part of strong, resilient health systems. As countries across the world grapple with containing the COVID-19 outbreak, we must also work together to ensure that the world’s most vulnerable children don’t miss out on the vaccines that prevent devastating illnesses like measles, polio, diarrhea, and pneumonia. In the face of this current challenge, it’s essential that we work together to protect essential health services like immunization to ensure that all people have a shot at living a healthy life protected from preventable disease.

Visit the VoICE World Immunization Week 2020 Social Media Toolkit for messaging and images to promote the broad benefits of vaccines. The toolkit is also available on the official World Immunization Week 2020 website.

References

  1. Kirigia, J.M., Gambo, L.G., Yolouide, A., et al 2009. Economic burden of cholera in the WHO African Region. BMC International Health and Human Rights. 9(8). doi: 10.1186/1472-698X-9-8
  2. Smith, R.D., Keogh-Brown, M.R., Barnett, T., et al 2009. The economy-wide impact of pandemic influenza on the UK: a computable general equilibrium modeling experiment. BMJ. 339. https://doi.org/10.1136/bmj.b4571
  3. Nandi A, Shet A, Behrman JR, et al. 2019. Anthropometric, cognitive, and schooling benefits of measles vaccination: Longitudinal cohort analysis in Ethiopia, India, and Vietnam. Vaccine. 37. https://doi.org/10.1016/j.vaccine.2019.06.025
  4. Bloom, D. E., Canning, D., & Shenoy, E. S. (2011). The effect of vaccination on children’s physical and cognitive development in the Philippines. Applied Economics, 44(21), 2777-2783. https://doi.org/10.1080/00036846.2011.566203
  5. Edwards CH, Bekkewold T, Flem E. 2017. Lost workdays and healthcare use before and after hospital visits due to rotavirus and other gastroenteritis among young children in Norway. Vaccine. 35. https://doi.org/10.1016/j.vaccine.2017.05.037
  6. Anekwe, T.D., Kumar, S. 2012. The effect of a vaccination program on child anthropometry: Evidence from India’s Universal Immunization Program. Journal of Public Health. 34(4). https://doi.org/10.1093/pubmed/fds032
  7. Gewa, C.A. and Yandell, N. 2011. Undernutrition among Kenyan children: contribution of child, maternal and household factors. Public Health Nutrition. 15(6). https://doi.org/10.1017/S136898001100245X
  8. Kotloff, K.L., Nataro, J.P., Blackwelder, W.C., et al 2013. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 382(9888). https://doi.org/10.1016/S0140-6736(13)60844-2
  9. Bhargava, A., Guntupalli, A.M., Lokshin, M. 2011. Health Care Utilization, socioeconomic factors and child health in India. Journal of Biosocial Sciences. 43(6). https://doi.org/10.1017/S0021932011000241
  10. Lee BY, Brown ST, Haidari LA et al. 2019. Economic value of vaccinating geographically hard-to-reach populations with measles vaccine: a modeling application in Kenya. Vaccine. 37(17). https://doi.org/10.1016/j.vaccine.2019.03.007
  11. Kusuma YS, Kaushal S, Sundari AB, et al. 2018. Access to childhood immunization services and its determinants among recent and settled migrants in Delhi, India. Public Health. 158. https://doi.org/10.1016/j.puhe.2018.03.006
  12. Arsenault, C., Harper, S., Nandi, A., et al. 2017. Monitoring equity in vaccination coverage: A systematic analysis of demographic and health surveys from 45 Gavi-supported countries. Vaccine. 5(6). https://doi.org/10.1016/j.vaccine.2016.12.041

World Immunization Week 2020 Social Media Toolkit

VoIce banner for World Immunization Week 2020

World Immunization Week 2020 (April 24-30) is an opportunity for immunization advocates across the world to promote the value of vaccines for protecting people of all ages against preventable diseases. Our VoICE social media toolkit provides messaging on the vital role that vaccines play in global health. Beyond saving millions of lives every year #VaccinesWork For All by strengthening our health care systems, protecting global health security, shrinking equity gaps, and more.

Join us in promoting the message that #VaccinesWork For All by sharing the evidence on the broad benefits of immunization!

VoICE Social Media Toolkit for World Immunization Week 2020

Download the VoICE World Immunization Week 2020 Toolkit for a series of social media messages and shareable images that highlight key evidence on the value of vaccines! Messaging covers the six main topics of the VoICE Compendium: Health, Education, Economics, Equity, Health Systems and Integration, and Global Issues.

The toolkit is also available as a downloadable PDF and all images can be easily copied or saved directly from this page.

Welcome to WIW 2020!

Immunization saves millions of lives every year. Yet, there are still nearly 20 million children worldwide who are not getting the vaccines they need.

We have it in our power to close this gap!

Welcome to World Immunization Week banner

#VACCINESWORK TO PROTECT OUR HEALTH

#DYK those with HIV, cancer, and weakened immune systems benefit from immunization of others through herd immunity?

https://bit.ly/immunization_HerdEffects

Herd Effects Children banner

#VaccinesWork for all by protecting people around us, especially those who are vulnerable like new babies, older adults, and people who are seriously ill.

http://bit.ly/CancerandImmunization

Herd Effects All Ages banner 2

Malnourished kids suffer the most from pneumonia, diarrhea and other vaccine-preventable infections.

It’s time to level the playing field!

Bit.ly/2OqdS7C

Undernutrition cycle

#VACCINESWORK TO IMPROVE EDUCATION

#DYK that immunization is linked to improved education and cognitive outcomes? Immunized children stay healthier so they miss less school and attain higher school grades.

https://bit.ly/VoICE_Education

#VACCINESWORK TO IMPROVE EDUCATION banner

#VACCINESWORK FOR ECONOMIES

Vaccines don’t just save lives; they keep the world’s most vulnerable people out of poverty. A 2018 @Health_Affairs study found the poorest households receive the most benefit from increased access to vaccines.

bit.ly/3a35ORd

Policy Poverty Quote

Studies show that vaccines can help stop poverty in addition to saving lives. Read the latest research on the economic benefits of vaccines.

#VaccinesWork for All

bit.ly/2MGAJui

Prevent Poverty banner

#VACCINESWORK FOR EQUITY

13.5 million children around the world still can’t access vaccines – these children are often the most vulnerable to disease and health disparities. We have it in our power to close this gap!

Leaving no child behind means ensuring the most marginalized – those touched by conflict or forced from their homes – have access to lifesaving #vaccines.

bit.ly/voice_migration

Vaccines are a tool for reducing gender, geographic, and sociocultural inequity – find the latest evidence on immunization and equity on VoICE:

http://bit.ly/2ILpP

https://bit.ly/34gn848

https://bit.ly/2Vzlx5p

Immunization For Equity

#VACCINESWORK FOR HEALTH SYSTEMS

Immunization can decrease hospital admissions, thus alleviating pressure on overburdened health systems, freeing up needed medical resources.

https://bit.ly/2V4H9Ye

In Kenya, rates of pneumonia hospitalizations in children <5 dropped by 27% after 4 years of PCV10. #VaccinesWork for All to reduce hospital admissions and free up more resources to treat and prevent other illnesses.

bit.ly/2V4H9Ye


#VACCINESWORK FOR HEALTH SECURITY

Between 2005-2014 nearly 400 infectious disease outbreaks (excluding measles) were reported to the @WHO, threatening the health security of the entire world.

View @Voice_Evidence’s feature issue on #outbreaks to learn more: http://bit.ly/voice_outbreaks

Immunization Outbreaks banner

2019 saw a record for measles outbreaks – more than 140,000 lives were lost, mostly children.

Measles is so contagious that the exposure of a single person without immunity to the virus can spark an outbreak that quickly burns through whole communities.

http://bit.ly/voice_outbreaks

Special edition: Pneumococcal conjugate vaccines in the global fight against child pneumonia

Mother holdes her child in Nepal

Pneumonia is responsible for more than 800,000 under-5 deaths each year—claiming a child’s life every 39 seconds. Vaccines against pneumococcus, Haemophilus influenzae type b (Hib), pertussis, measles, and influenza are important to help protect children from disease and prevent the lasting health, equity, and socioeconomic effects of pneumonia. This week, country leaders, scientific experts, program and policy officials, and advocates from around the world will meet in Barcelona to elevate pneumonia on national and global health agendas and raise the call for action against this common, serious, preventable cause of child illness and death.

Key Messages

  1. Pneumonia remains a leading killer of children under 5 worldwide, disproportionately affecting the poorest children with lasting effects
  2. Immunization is a key part of a comprehensive approach to prevent and control childhood pneumonia, along with interventions like breastfeeding, handwashing, reducing indoor air pollution, and appropriate treatment
  3. Vaccines that help protect against pneumonia have even broader benefits, like helping to avert potentially catastrophic medical costs that can push families into poverty
  4. This week’s Global Forum on Childhood Pneumonia calls for global action to set practical, evidence-based plans to end preventable child pneumonia deaths

The Global Forum on Childhood Pneumonia

For three days this week, Barcelona will host hundreds of country leaders, scientific experts, program and policy officials, and advocates as they raise awareness of the global burden of child pneumonia, recognize progress made, and call for commitments to concrete strategies to prevent and control this leading cause of child death. Fighting for Breath: The Global Forum on Childhood Pneumonia serves as a call to action to deliver concrete measures to save children from the disease that claims more than 800,000 young lives each year.

To do this, we need action grounded in evidence—to recognize the importance of a comprehensive approach to pneumonia prevention and control, including the broad, lasting benefits of immunization. Vaccines against causes of pneumonia, like pneumococcal conjugate vaccines (PCV), are vital parts of this strategy and can help protect children from disease and prevent the lasting health, equity, and socioeconomic effects of pneumonia.

Three things to know about the benefits of PCV

1. Pneumonia is the leading infectious cause of death in children under 5 years of age, and disproportionately affects the poorest children across the world, impacting their health, growth, and development. Pneumococcus is a common bacterial cause of pneumonia, which makes PCV a valuable tool to prevent disease, promote health, and fight poverty by preventing medical costs-related impoverishment, interrupting the cycle of infections, and helping to improve growth.

Stay tuned! New evidence on the cost of pneumonia and value of pneumococcal vaccines will be presented at the Global Forum.

2. Use of PCV (among other vaccines) has been shown to reduce health care costs and need for treatments like antibiotics by preventing or reducing the severity of vaccine-preventable disease. This in turn reduces individual health care expendituresthe burden on health systems, and the development of antibiotic and multi-drug resistance.

3. PCV and other vaccines can also help improve health equity, especially when immunization programs reach those who have less access to health services. These populations are often at highest risk for vaccine-preventable diseases and related complications, and include those who are poormalnourished or immunocompromisedHIV positive, and other marginalized populations and minority groups.

Progress in PCV products and prices

Following on Gavi’s success in achieving lower prices for Hib-containing pentavalent vaccine, another vaccine for childhood pneumonia and meningitis, market-shaping success has also been achieved for PCV. For Gavi-eligible countries, PCV prices have been steadily declining and new multi-dose presentations that help reduce cold chain requirements and price per dose are now availableThis is the third straight year that Pfizer has reduced the price of PCV for developing countries, now down to US$2.90.

The PCV product landscape continues to expand—a new pneumococcal conjugate vaccine is here! PNEUMOSIL® is a 10-valent PCV developed by Serum Institute of India, Pvt., Ltd. and PATH, with funding from the Bill & Melinda Gates Foundation. It is now WHO-prequalified and will be available to low- and middle-income countries at a target price of US$2.00 per dose. Three WHO-prequalified PCV products are now available: PNEUMOSIL, Synflorix® (GSK), and Prevenar-13® (Pfizer).

A global call for action to end preventable child pneumonia deaths

PCV and other vaccines are critical parts of our pneumonia prevention and control toolkit, but the best strategy to effectively combat pneumonia is a comprehensive, evidence-based approach that includes a package of interventions. That means national and global commitments to protecting children—especially the most vulnerable—by promoting exclusive breastfeeding and improving nutrition, preventing HIV, reducing indoor air pollution, improving access to clean water and effective sanitation, ensuring early diagnoses and treatment, and fully immunizing every child.

Infographic by WHO/UNICEF, 2013, Ways to end preventable child pneumonia deaths
WHO/UNICEF, 2013

Ending preventable child pneumonia deaths is a challenge of global proportions that demands dogged determination; practical, evidence-based strategies; and a unified voice committed to meeting the Sustainable Development Goals and Integrated Global Action Plan for the Prevention and Control of Pneumonia and Diarrhea targets.

Learn more about pneumonia and the value of immunization in the VoICE Compendium

Follow @Stop_Pneumonia for updates from this week’s Global Forum on Childhood Pneumonia and @voice_evidence to learn more about the broad, lasting benefits of immunization.

Photo credits: Amanda Mustard for Johns Hopkins University and Thomas Rippe

Vaccination: Helping children think, learn and thrive

Infographic describing Immunization, schooling and future prospects

A healthy child is more likely to attend school, performs better in school and attends school for longer than a child who is often ill or has suffered permanent disabilities as a result of illness. In this Feature, VoICE explores how vaccine-preventable infections affect cognitive development and schooling, and highlights evidence of the effect vaccination can have in protecting a child’s neurologic development, educational prospects and ultimately, future productivity.

Key Messages

  1. Common childhood illnesses cause children to miss school. Immunized children miss less school.
  2. Recurring episodes of diarrhea in young childhood can delay a child from starting school and affect physical growth and normal cognitive development during childhood. Vaccine-preventable rotavirus is the most common cause of severe diarrhea.
  3. Immunization against measles can increase the number of years of schooling a child achieves and may also improve cognitive scores, compared to unimmunized children.
  4. Some vaccine-preventable infections carry the risk of long-term hearing, psychosocial and neurological disabilities that negatively impact a child’s social functioning and educational prospects.
  5. On average, globally, each additional year of schooling can increase a child’s future adult earnings by more than 12%.

Immunization protects our children’s future prospects

Most people think of vaccines as important for preventing specific diseases and infections during childhood, but may not realize the extent to which immunization can strengthen a child’s future prospects well into the school years and beyond. Growing evidence is illuminating the link between vaccination and improved cognitive functions, education, and ultimately, adult productivity. In essence, vaccination may help improve a child’s ability to learn, think and thrive in society as a result of educational attainment, cognitive reasoning and thinking skills.

Immunization, Schooling and future Prospects

Vaccine-preventable diseases, immunization and educational attainment

Vaccinated kids miss less school

The most obvious link between immunization and education is that preventing bouts of illness means kids miss fewer school days. A study of school absenteeism in the US found that nearly 50% of absences were due to illness. A second US study found that schools that offered flu vaccine to their students reduced the risk of any child getting the flu by 30%, regardless of vaccination status. Children vaccinated against the flu missed 1.5 fewer days of school per 100 school days compared to those who did not receive flu vaccine. Thirty years ago, Varicella infections (chickenpox) caused a child to miss nearly 9 days of school, not to mention work missed by parents taking care of a sick child. But the introduction of chickenpox vaccine in 1995 has drastically reduced infections, hospitalizations and deaths from this common infection, preventing more than 3.5 million cases each year in the US, according to the CDC.

Infections and schooling delays

Rotavirus is the most common cause of severe diarrhea in young children worldwide, and researchers in Brazil found that recurrent bouts of diarrhea affect school readiness and long-term educational attainment. In children living in a Brazilian shantytown, the greater the number of episodes of persistent diarrhea before age two, the more delayed a child was in terms of school readiness. Overall, each episode of diarrhea delayed a child’s starting school by 0.7 months. Likewise, 6-10 years later, increasing episodes of diarrhea before age two predicted delays in age-appropriate educational attainment. Some infections, such as tuberculosis meningitis, although rare, significantly increase the risk of major educational delays. From a study in Western Cape, South Africa, among children who were well enough to attend school after surviving tuberculosis meningitis, more than half had failed at least one school grade.

Measles vaccine can help increase extent of education received

Measles infection has a well-known prolonged negative impact on the immune system, increasing the risk of other illnesses for up to 3 years after recovering from measles. A 2019 analysis of survey data from school aged children in Ethiopia, India and Vietnam shows that children vaccinated against measles achieved 0.2-0.3 years of additional schooling compared to children who did not receive the measles vaccine. As depicted in the graphic below, note that this value is as high as 0.8 years of schooling by age 11-12. Similarly, data from a poor, largely rural South African community found that for every 6 children vaccinated against measles, one additional grade of school was achieved. In terms of initial enrollment in school, the phased introduction of measles in Bangladesh in the 1980’s resulted in boys being more than 7% more likely to be enrolled in school if they were vaccinated during the first year of life, compared to unvaccinated boys or those vaccinated later in childhood. This effect was not observed for girls, but may suggest that overall physical and cognitive health of children – as a result of their measles vaccination status – played a role in parent’s decisions to enroll their children in school.

Measles Vaccination Associated with Increased Schooling

Maternal vaccination can help a child’s education

In 1974, a randomized trial of tetanus vaccine was designed to determine how well maternal vaccination would protect infants born to mothers in Bangladesh from tetanus. The study showed a significantly reduced risk of tetanus infection and death among infants born to mothers who had received the vaccine. Notably, 20 years later, researchers found a clear pattern of increased educational attainment among children whose mothers received tetanus vaccine during pregnancy. Helping to explain this observation is the fact that up to 50% of children who survive neonatal tetanus may have long-term cognitive impairment as a result of the infection.

Vaccine-preventable diseases affect the ability to learn, think and function socially

Long-term impairments resulting from vaccine-preventable infections can reduce a child’s educational prospects in several ways. Not only may the impairment itself represent a barrier to learning and future productivity, as in the case of significant cognitive delays, but educational support for children affected by these and other impairments may be lacking or nonexistent. In many places around the world, educational systems and local school are stretched exceedingly thin and unable to provide specialized assistance to children with hearing, vision, developmental or other impairments.

Vaccine preventable infections in childhood can negatively affect a child's education

Hearing impairments

In the era before the introduction of pneumococcal conjugate vaccine (PCV) in the US, pneumococcus was the most common cause of serious and recurring ear infections in children. In comparison to life-threatening meningitis or severe pneumonia brought on by pneumococcal infection, an ear infection may seem trivial. But from the perspective of learning, ear infections can have serious consequences. Multiple ear infections in early childhood increase the risk of hearing loss, and that speech and language develops during the same time in which most children are at the greatest risk of ear infections. These factors help explain why children who spent more time with ear infections during early childhood had lower cognitive, speech, language development and even IQ than children who suffered less time with ear infections, according to a 1990 study in the US. More recently, a 2015 review of long-term impairments resulting from invasive meningococcal disease – which is relatively rare in the era of meningococcal vaccines – was significantly associated with permanent hearing loss in survivors.

Social and psychological impairments

Another set of challenges presented to survivors of vaccine-preventable diseases includes behavioral, social and psychological disorders. The invasive meningococcal disease review above highlighted evidence that children who survived invasive meningococcal infections were nearly 15% more likely to have a significant psychological disorder 3-5 years after the disease than children who did not have the disease, and two studies found a significant association between the disease and later development of Attention Deficit Hyperactivity Disorder (ADHD).

Vaccine-preventable brain and brain-related infections and long-term cognitive impairment

Vaccines can prevent several infectious causes of severe brain and brain-related infections such as meningitis or encephalitis. These types of infections are not only life-threatening but are highly associated with impaired thinking and learning after infection, sometimes for the rest of one’s life. Vaccines that prevent these infections thus help protect and preserve one’s future ability to learn, engage socially and thrive in society.Infection with Japanese encephalitis virus (JEV), which circulates almost exclusively in Asia, usually results in mild or undetectable symptoms. However, in those who develop encephalitis, a serious inflammation of the brain, 1 in 4 do not survive. Among those who do survive, up to 50% are left with permanent cognitive, psychological or neurological disabilities. An effective vaccine is available and the WHO recommends its inclusion in the national immunization schedules of heavily affected countries.Another life-threatening infection of the central nervous system is meningitis, which may have viral or bacterial causes. A large portion of the most severe meningitis infections were caused by three bacteria – pneumococcus, Hib and meningococcus – which are now largely vaccine-preventable. Pneumococcal, Hib and meningococcal infections have been responsible for the majority of meningitis deaths among children and for significant numbers of permanent cognitive disabilities, making their prevention high on the list of priorities for safeguarding a child’s future prospects. In The Gambia, 58% of children who survived pneumococcal meningitis had long lasting negative health outcomes. Half had major disabilities such as mental retardation, hearing loss, motor abnormalities, and seizures. A systematic literature review of studies across Africa found that 25% of children who survived pneumococcal or Hib meningitis had neuropsychological deficits.

The link between diarrhea, physical growth and cognition

Especially during early childhood, good nutrition and physical growth are needed for normal cognitive development. Diarrhea, especially severe or recurring diarrhea, limits the absorption of nutrients in the body, which can affect physical and cognitive development in the long-term. (See the VoICE Featured Issue on Nutrition, Growth and Development). Many rotavirus infections can be prevented through the use of existing vaccines. Prevention of diarrhea is another way to safeguard cognitive development, based on these sobering facts:

Some vaccines have been linked to improved learning and cognitive development

Some evidence in the last 10 years points to a positive link between vaccination in early childhood and a corresponding gain in cognitive and learning tests in later childhood. A small study from the Philippines found that children immunized with 6 basic vaccines scored better on three cognitive tests (verbal, mathematics and language) at age 11 compared to children who received none of these 6 vaccines. A 2019 analysis of survey data from India, Ethiopia and Vietnam found that children vaccinated against measles scored better on cognitive tests of language development, math and reading than children who did not receive measles vaccines.

Vaccination as an investment in future productivity

Reporting on the Philippine study of cognition and vaccination, David Bloom and colleagues at Harvard University note that improvements in a child’s health translate into better earning potential and productivity as an adult, and thus describe vaccination as “an investment in human capital”, highlighting several studies that support this idea. Educational attainment is an important part of the equation for reaping the rewards of such investments. A 2014 World Bank review of the returns to schooling worldwide found a significant positive relationship between additional years of schooling and future adult wage earnings. Not only were the returns from schooling greatest in low- and middle-income countries, but the highest returns to schooling came from the primary years of education – years in which the influence of early childhood illnesses is the strongest. On average across Africa, the report concludes that an additional year of schooling would yield a 12.4% increase in future adult earnings.A healthy child is more likely to attend school, performs better in school and attends school for longer than a child who is often ill or suffering permanent disabilities as a result of illness. The list of consequences from vaccine-preventable illnesses is long and frightening. Each threat erased from that list by vaccination is another hurdle removed from a child’s path to an education and a full and productive adulthood.

Commentary from the VoICE editors

The literature investigating the linkages between immunization, education and cognition represents a complex web of research areas spanning epidemiology, neuroscience, economics, education and demography. Studies specifically and quantitatively looking at the relationships between vaccines and education or cognition are relatively few, and some are older than the literature typically covered in VoICE. Although the positive link between immunization and educational attainment is generally accepted, the lack of new studies on this topic highlights the need for additional focus on this area of study. Although the complexity of these linkages makes quantifying the effect of immunization on education and future productivity difficult, all the literature reviewed in VoICE demonstrates a clear positive – and logical – relationship between immunization and improvements in thinking, social development, schooling and educational success.

Vaccine-preventable Outbreaks: Becoming All Too Common and Costly

Infographic of words related to outbreak

From Abuja to Atlanta, recent infectious disease outbreaks have all too commonly captured the regular news headlines. In this Featured Issue on vaccine-preventable disease outbreaks, the VoICE team goes past the headline, down to the fine print. We bring you an evidence-backed overview of vaccine-preventable infectious disease outbreaks worldwide, with a special focus on the circumstances that increase the likelihood of an outbreak, the less-obvious health and economic consequences, and a “top five” list for outbreak prevention and preparedness.

A selection of VoICE evidence in this issue

Paniz-Mondolfi AE, Tami A, Grillet ME et al. 2019. Resurgence of vaccine-preventable diseases in Venezuela as a regional public health threat in the Americas. Emerging Infectious Diseases. 25(4).

Suijkerbuijk AWM, Wondenberg T, Hahne SJM et al. 2015. Economic costs of measles outbreak in the Netherlands, 2013-2014. Emerging Infectious Diseases. 21(11).

Culver A, Rochat R, Cookson S 2017. Public health implications of complex emergencies and natural disasters. Conflict and health. 11(1).

Hammer CC, Brainard J, Hunter PR 2018. Risk factors and risk factor cascades for communicable disease outbreaks in complex humanitarian emergencies: a qualitative systematic review. BMJ Global Health. 3.

Calugar A, Ortega-Sanchez I, Tiwari T et al. 2006. Nosocomial pertussis: Costs of an outbreak and benefits of vaccinating health care workers. CID. 42.

Coltart CE, Johnson AM, Whitty CJ 2015. Role of healthcare workers in early epidemic spread of Ebola: policy implications of prophylactic compared to reactive vaccination policy in outbreak prevention and control. BMC Medicine. 13(271).

Huber C, Finelli L, Stevens W 2018. The economic and social burden of the 2014 Ebola outbreak in West Africa. JID. 22(5).

Takahashi S, Metcalf JE, Ferrari MJ et al. 2015. Reduced vaccination and the risk of measles and other childhood infections post-Ebola. Science. 347(6227).

Dayan GH, Ortega-Sanchez IR, LeBaron CW et al. 2005. The cost of containing one case of measles: the economic impact on the public health infrastructure — Iowa, 2004. Pediatrics. 116(1).

Constenla D., Carvalho A., Guzman NA. 2015. Economic impact of meningococcal outbreaks in Brazil and Colombia. Open Forum Infectious Diseases. 2(4).

Colombini A, Badolo O, Gessner BD et al. 2011. Cost and impact of meningitis epidemics for the public health system in Burkina Faso. Vaccine. 29.

Pike J, Tippins A, Nyaku M et al. 2017. Cost of a measles outbreak in a remote island economy: 2014 Federated States of Micronesia measles outbreak. Vaccine. 35(43).

Bambery Z, Cassell CH, Bennell RE et al. 2018. Impact of hypothetical infectious disease outbreak in US exports and export-based jobs. Health Security. 16.

Hagan JE, Greiner A, Luvsanshavar UO et al. 2017. Use of diagonal approach of health system strengthening and measles elimination after a large nationwide outbreak in Mongolia. Emerging Infectious Diseases. 23.

World Health Organization 2017. Weekly epidemiological record, Cholera vaccines: WHO position paper – August 2017. WHO Weekly epidemiological record. 92(34).

Jonas, O., Katz, R., Yansen, S., et al. 2018. Call for independent monitoring of disease outbreak preparedness. BMJ. 361.

Key Messages

  1. Infectious disease outbreaks can happen anywhere and have significant, and often hidden, social, health and economic repercussions.
  2. A large proportion of recent infectious disease outbreaks are of vaccine-preventable diseases.
  3. The likelihood or severity of an outbreak is increased by factors such as low vaccination coverage, crowding, poor sanitation, malnutrition, and human mobility.
  4. Outbreak prevention and preparedness needs to be systematically integrated into health systems and specific areas must urgently be strengthened to include immunized healthcare workers, streamlined health communications, and ready surveillance systems.

Introduction

Disease outbreaks happen in nearly every corner of the globe – from the remote Amazon to Amsterdam. An analysis of a World Health Organization (WHO) epidemics database found that from 2005-2014, nearly 400 outbreaks of infectious disease (not including measles) were reported to the WHO. Nearly 40% of these outbreaks were due to vaccine-preventable diseases (VPDs) – with yellow fever, polio, meningococcal disease and cholera accounting for 9/10  of the outbreaks due to VPDs.  The proportion of outbreaks caused by VPDs was as high as 70% in the African region. The ubiquity of disease outbreaks globally speaks to the range of complex factors that contribute to outbreaks of various infectious diseases, but there are some combinations of factors that can easily ignite an outbreak of epidemic proportions.

Outbreak, epidemic, or pandemic?

Outbreak Highlight Box-Outbreak Epidemic Pandemic

A Fire Waiting to Happen:

Circumstances that increase the risk of outbreaks

There are a triad of elements that influence the likelihood and severity of an infectious disease outbreak. These include factors related to:

  1. The Pathogen – aspects of the disease agent itself (virus or bacteria), such as how it is transmitted from person to person, how contagious it is, the incubation period before symptoms appear, how severe the infection may be and how likely it is to result in death.
  2. The Population – factors affecting the state of health of the population at risk, including the proportion vaccinated, malnourished or living in sub-optimal conditions such as overcrowding, and how people move on small or large spatial scales.
  3. The Environment – generally refers to environmental factors that affect the spread of disease such as access to clean water and sanitation, access to health care, social norms and cultural practices – for example in the case of Ebola where traditional burial practices bring people into contact with infected bodily fluids which transmit the virus.

Figure 1: Pathogen, population, and environmental factors can ignite an outbreak of infectious disease.

Outbreaks

An outbreak can ignite when sparked by only a handful of the factors described above, such as in the case of measles or pertussis – two highly contagious pathogens which can rapidly take advantage of gaps in vaccine coverage. In other circumstances, parts of all three elements – pathogen, population and environment – are present and create the perfect conditions to kindle an outbreak.

Cracks in the immunization firewall

A high firewall of immunization coverage with very very few gaps is required to protect populations from outbreaks of highly transmissible and contagious infections, such as measles or pertussis, which have the potential to spread rapidly and far. An infection like measles is so contagious that almost all susceptible people who are exposed will become infected meaning that about 95% of a community needs to be protected to stop measles virus transmission. Add to that the fact that contagiousness occurs before the telltale rash (and very often before anyone knows what is causing the illness), and you can see how just those two pathogen-related factors cause some outbreaks to explode. In a community with lower than 95% vaccine coverage, the exposure of a single person without immunity to the virus is the single spark that is needed to start an outbreak that quickly burns through a community of people who have little or no immunity. The connection between measles and low vaccination coverage is so strong that some researchers describe measles outbreaks as being a “canary in a coalmine” that brings to light programmatic weaknesses in immunization coverage in places where data on vaccination coverage is thin or unreliable.

Figure 2: Factors contributing to measles outbreaks.

The firewall for a disease like Ebola must be just as strong but for different reasons. Ebola is not very contagious when compared to other infections, but has an exceedingly high risk of death – up to 70% with some strains. (An animated visualization from the Washington Post of the relative contagiousness and mortality risk of different diseases.) When and exactly where the disease will appear is impossible to predict (see “The case of Ebola, a zoonotic infection”, below) and a vaccine against the disease has not yet been approved. For these reasons, outbreak control measures for Ebola, including significant efforts to find people who have been exposed, must be swift and widespread. An experimental vaccine for Ebola is being used in a “ring” vaccination strategy to vaccinate everyone who has come in contact with someone who has the disease, and has proven to be nearly 100% effective in preventing infection, if administered soon enough after exposure. Gaps in this vaccination ring mean the deadly disease has the potential to continue spreading.

Complex emergencies

Global socio-political events, including armed conflicts and other complex humanitarian emergencies, can result in a highly flammable set of circumstances – a “box of matches” containing nearly every population and environmental factor, which can easily spark a significant outbreak. In a study of the overlap between complex humanitarian emergencies and disease outbreaks, researchers found that more than 40% of complex emergencies that occurred between 2005-2014 were associated with an outbreak of infectious disease, with a high likelihood that the outbreak was vaccine-preventable.

The mass migration of people that often results from complex humanitarian emergencies can set off a “risk factor cascade”, that includes decreasing vaccination coverage, undernourishment, overcrowding, and poor sanitation, dramatically increasing the risk of an outbreak with each added cascade factor.

When environmental conditions are poor and pathogen-related factors are significant, only a tiny spark is required to ignite an outbreak, as is often the case with cholera. The bacteria that causes cholera (Vibrio cholera), a highly contagious diarrheal disease, can be quickly passed to large numbers of people through contaminated water in crowded and poorly-resourced settings such as urban slums or refugee camps that have poor access to clean water and sanitation. Rainfall further spreads the contaminated water, sustaining the outbreak. Population factors, such as undernutrition further worsen the disease.  Undernourished people are at greater risk of severe cholera infections and of dying from the infection.

Figure 3: Factors contributing to cholera outbreaks.

Outbreaks, Figure 3, Cholera

The case of Ebola, a zoonotic infection

Most vaccine-preventable outbreaks are due to pathogens which circulate constantly among humans, causing spikes in disease when population and environmental conditions allow. Ebola, however, is a zoonotic infection, meaning that the normal reservoir for the pathogen is among animals, most likely bats. Ebola outbreaks among humans are triggered when people come into contact with infected animals (such as through the consumption of bush meat from infected primates), become ill and then pass the virus to other humans where it spreads until it can be contained.

Predicting when and where the virus will strike and spark an outbreak is thus very difficult, which significantly adds to the challenges of planning for, controlling and mitigating the impact of outbreaks. Ebola is one of several diseases of zoonotic origins  that has the potential to ignite a global pandemic, according to USAID.


The Repercussions of Vaccine-Preventable Outbreaks

While outbreaks of measles and Ebola have been widely covered in the news media, a less visible topic has been the significant – and sometimes long-term – health and economic repercussions that come along with outbreaks of these and other diseases.

Repercussions on health systems

By definition, an outbreak is the occurrence of disease in a population that rises above expected levels. Although contingency plans may be in place for dealing with an outbreak, health staff, funding, medical supplies and other resources are often diverted to outbreak control, weakening the provision of other health services. In one example from Burkina Faso in 2007, meningitis epidemics disrupted health services at every level. Impact on all people seeking healthcare included longer wait times to be seen, increased time for lab test results, higher stress among caregivers and an increase in the number of misdiagnoses by overtaxed health care workers (HCWs).

Repercussions for healthcare workers

The burden on HCWs, in fact, extends beyond exhaustion and the mental toll of working in outbreak conditions. Health workers themselves are at significant risk of becoming victims of an infectious disease outbreak and passing on the infection to others, in particular before the infectious agent has been identified. HCWs can account for a substantial proportion of disease cases. A recent study using data from historical outbreaks of Ebola in Guinea and Nigeria, found that (had a fully effective vaccine been available at the time of those outbreaks) prophylactically vaccinating healthcare workers would have decreased the size of the Ebola epidemics in those countries by 60-80%. In the US, researchers estimated that ensuring full vaccination of healthcare workers would prevent more than 45% of exposures to pertussis that occur in healthcare settings. These are only two of many examples illustrating the disproportionate burden of disease cases among HCWs, all of which highlight critical gaps in vaccine coverage among people at significantly increased personal risk, and risk of infecting others. (For more on the WHO’s recommendations for immunizing health care workers.)

Repercussions of every kind: The Ebola firestorm

Outbreaks of exceptionally deadly infectious diseases such as Ebola can cause a cascade of events affecting every person and sector in a community and thus represent a firestorm of all the potential repercussions of an outbreak occurring at once. Huber et al described the devastating and far-reaching impact of the 2014 Ebola outbreak in West Africa, including more than half a million people experiencing food insecurity, school closures lasting more than 7 months, tens of thousands of children orphaned, a huge proportion of the health workforce killed by the disease, infant, maternal and child deaths from lack of skilled health workforce and a 97% reduction in surgical capacity, to name a few. A second study projected that the crippling of immunization programs resulting from the Ebola outbreak could double the number of people at risk for measles, ultimately killing nearly as many people as Ebola itself.

Ebola Treatment Center in Beni, Democratic Republic of the Congo’s North Kivu Province
At ALIMA’s (The Alliance for International Medical Action) Ebola Treatment Center in Beni, Democratic Republic of the Congo’s North Kivu Province, health workers care for patients infected with Ebola within ALIMA’s innovative biosecure emergency care unit – the CUBE.

Economic repercussions: costs of outbreaks

Adding to the secondary health and societal costs of infectious disease outbreaks are the actual monetary and economic impacts, which are significant even in a relatively small and quickly contained outbreak. The larger and longer an outbreak, the more significant its macroeconomic impacts on productivity, import & export losses, reduced tourism revenue and consumption.

From cholera to measles to Ebola, health economists have published several studies on the economic impact of outbreaks, covering direct costs of outbreak management to slowed national economic growth as a result of outbreaks. Direct costs to health systems include outbreak investigation costs such as personnel, supplies, travel expenses to find people exposed to infection and outbreak containment efforts including vaccination or prophylactic treatment costs for those exposed. Costs to individual families seeking treatment can be significant and have long-term economic consequences. Productivity losses and reduced consumption and revenue directly affect nations dealing with outbreaks, but shifts in imports and exports internationally can impact other nations economically, despite not being directly affected by the outbreak. Just some of the economic repercussions can be found in the cases below:


Outbreak Prevention and Preparedness

The prevention, mitigation and control of infectious disease outbreaks is becoming more urgent, while the number of emerging diseases increases, populations are more mobile and economies are stretched thin. Addressing infectious disease outbreaks must be a high political priority, requiring investments of both financial support and political will. But investments in what exactly?

It will come as no surprise that vaccination features prominently in our “TOP FIVE” list of investments that must be made to better prevent and prepare for outbreaks of infectious disease. What may be surprising is that financing, purchasing and delivering vaccines to the general population is only one of the necessary steps towards ensuring that the full potential of immunization can be realized in helping to prevent, mitigate and control outbreaks. Clear and actionable preparedness plans, robust health systems with increased access to health care, and significantly increased investments in disease surveillance and health communication round out our list.

Top Five Investments In Outbreak Prevention And Preparedness

1. Investment in health systems, including routine immunization

A country’s ability to prevent, detect and respond to outbreaks is tied to the strength and capacities of its health system overall. As such, a 2018 multi-stakeholder outbreak preparedness framework includes strengthening overall public health system capacity as the first of four pillars in the prevention of significant disease epidemics and pandemics.

National and subnational health systems supported by recommended levels of funding, high political priority and strategic planning processes that include the integration of emergency preparedness and everyday health systems operations are more resilient to emergencies such as disease outbreaks, and can recover more quickly. A 2016 WHO-led consultation with countries in the African region found that health systems and health security-related structures functioned independently from one another, but that strong support existed for the integration of emergency prevention and preparedness in broader health systems.

Given the high proportion of outbreaks due to vaccine-preventable infectious diseases, immunization has an especially important role to play in the prevention of disease outbreaks, and is thus critical for emergency prevention and preparedness.

2. Full immunization for health workers

High coverage of routine immunization is a critical firewall to prevent outbreaks from occurring, and vaccination of healthcare workers is especially critical to minimizing the spread of an emerging outbreak. Several studies have demonstrated the significant return on investment to be had by ensuring HCWs are fully immunized, given that HCWs often account for a disproportionately large number of disease cases. In the US study looking at prevention of the spread of pertussis referenced above, the financial return on vaccinating healthcare workers in hospitals was estimated to be nearly two and a half times the cost invested. A similar study of pertussis vaccine and HCWs in the Netherlands estimated the return on investment to be four times as great as the initial cost.

3. Actionable preparedness plan

Despite strong evidence that prevention and preparedness provide a sizeable return on investment, compared to the costs of an unchecked outbreak of disease, between 2016 and 2018 only one third of countries had assessed their own capacity to prevent, detect and control disease outbreaks.[1] That number has now risen to just under half, but nearly 80% of countries who have completed a preparedness assessment are wholly or partially unprepared for an outbreak of disease.[1] Experts argue that the cycle of panic and neglect in addressing disease outbreak readiness is a crisis of global proportions, and one which can only be broken by implementing and monitoring concrete preparedness plans.

4. Public health communications

Following recent global disease events like Ebola and SARS, which ignited global panic about the outbreaks and their impact, recognition has been increasing of the importance of consistent, clear and culturally sensitive communication with the public around health issues. Investment of money and time in this area, however, still lags behind the need. The WHO’s Outbreak Communication guidelines emphasize not only what needs to be done to communicate during an outbreak, but also the importance of building and maintaining trust in national and health authorities among all communities as a foundation for health communications and care seeking overall. Trust in an existing foundation of open, clear communication can help immunize against panic and increase compliance with measures intended to control and end outbreaks.

5. Infectious disease surveillance

The importance of disease surveillance, robust enough to detect outbreaks early, cannot be overstated, and yet, it is an area that is often poorly integrated in the broader public health system, and is chronically underfunded. Considered an essential public health capacity, investments in surveillance as it relates to outbreak detection and control are likely to have important benefits for other health priorities and diseases. For example, polio detection systems in the Americas were leveraged to better detect measles and rubella. Likewise, laboratory experience with measles and rubella surveillance led to the early detection and response to the H1N1 influenza virus in Mexico in 2009.

In summary, the specifics of the strategy for implementing each of these actions vary based on the type of outbreak. For example, the current vaccination strategy for Ebola includes finding and vaccinating all people who have come in contact with someone who has the disease (and all of those contacts’ contacts) to form a “ring” of immunity around disease cases. By contrast, measles and pertussis vaccines are recommended for all children worldwide during early childhood. Despite such differences in the specific approach needed, each of these five areas above are critical for mitigating the immediate impact and secondary repercussions of all future outbreaks.

[1] Jonas, Katz, et al. Call for independent monitoring of disease outbreak preparedness. BMJ. 2018;361:k2269 doi: 10.1136/bmj.k2269


Editorial Commentary

“We are witnessing an apparent increase in the magnitude and frequency of outbreaks due to vaccine-preventable diseases, as adroitly described in this VoICE Featured Issue. Such outbreaks are, by definition, preventable and thus a tragedy, resulting in pointless deaths, countless disabilities, loss of productivity, and economic costs. We must do better. We call on policy makers, community leaders, and the global public health community to improve surveillance systems to detect outbreaks as early as possible, improve vaccination coverage to ensure all children are appropriately immunized, and effectively communicate the benefits of vaccination so trust in public health is restored. We will face new infectious disease threats. We must control those diseases for which we already have safe and effective vaccines so we are best prepared to deal with the emerging ones.”

William Moss, MD, MPH
Interim Executive Director, International Vaccine Access Center

William Moss, MD, MPH is Interim Executive Director, at the Johns Hopkins Bloomberg School of Public Health’s, International Vaccine Access Center (IVAC), a pediatrician and infectious disease specialist who has dedicated the last three decades to improving the lives of children through better treatment and prevention of infectious disease. Dr. Moss has made significant contributions in many areas, including HIV, malaria, complex humanitarian emergencies and especially measles, for which he is a member of the World Health Organization’s expert Working Group on Measles and Rubella.

World Immunization Week 2019

Infographic showing 4 different cartoon families under 1 umbrella, text that says "Children with cancer, and other people with weakened immune systems, rely on vaccination and herd immunity to protect them from infection.""

Social Media Toolkit

Using evidence for advocacy: Visit the 2019 World Immunization Week social media toolkit! Explore our messages, graphics, and gifs illustrating how #VaccinesWork to keep us #ProtectedTogether. Topics include:

  • #ProtectedTogether: Herd immunity
  • #ProtectedTogether: Mothers and babies
  • #ProtectedTogether: Family-level economic protection
  • #ProtectedTogether: Country-level economic protection
  • #ProtectedTogether: Strengthening health systems

Download the IVAC VoICE WIW Social Media toolkit, with instructions to download animations.

Access all of the materials in this folder.

#ProtectedTogether: Herd immunity

Tweet 1a

Even unvaccinated kids are protected against rotavirus when coverage is high. @VoICE_Evidence #ProtectedTogether #VaccinesWork http://bit.ly/2YZs5Lv

Tweet 1b

Children with cancer and those with weakened immune systems rely on vaccination and herd immunity for protection from vaccine-preventable diseases. Vaccines help ensure these kids are #ProtectedTogether! @VoICE_Evidence #VaccinesWork http://bit.ly/2Kqphnp

Tweet 1c

3 for 1 deal on preventing pneumococcal infections! #VaccinesWork #ProtectedTogether @VoICE_Evidence http://bit.ly/2G34qBq

#ProtectedTogether: Mothers and babies

Tweet 2a

Moms get vaccinated to protect themselves AND their children – before and after they are born #ProtectedTogether #VaccinesWork @VoICE_Evidence http://bit.ly/2G2uxbF

#protectedTogether Gif

Tweet 2b

Children of empowered Nigerian mothers more than twice as likely to be vaccinated. Empowerment means mothers and children are #ProtectedTogether. #VaccinesWork @VoICE_evidence  http://bit.ly/2P1FluL

Mothers holding their children

Tweet 2c

Empowering women can lead to greater vaccination rates among children. #ProtectedTogether #VaccinesWork @VoICE_Evidence http://bit.ly/2UuQ6vg

Mothers holding their children

#ProtectedTogether: Family-level economic protection

Tweet 3a

4.5 million cases of poverty prevented with… measles vaccine! Health and wealth #ProtectedTogether #VaccinesWork @VoICE_Evidence http://bit.ly/2UKpRAj

Measles vaccination protects health and wealth

Tweet 3b

Costs to treat diarrhea push 160,000 Ethiopian families into poverty. Rotavirus vaccines, help health & wealth stay #ProtectedTogether. @VoICE_Evidence #VaccinesWork http://bit.ly/2KprjUM

vaccines helps health and wealth

Tweet 3c

Costs to treat pneumonia pushed 59,000 Ethiopian families into poverty in 2013. But now PCV and Hib vaccines help the health & wealth of Ethiopian families stay #ProtectedTogether. @VoICE_Evidence #VaccinesWork http://bit.ly/2KprjUM

Tweet 3d

#VoICE_Evidence: Costs to treat their child’s rotavirus infection were “catastrophic” for 1 in 3 Malaysian families. Vaccines ensure families’ health and wealth are #ProtectedTogether #VaccinesWork http://bit.ly/2GdFisG

#ProtectedTogether: Country-level economic protection

Tweet 4a

PREVENTED: 24 million cases of poverty due to medical expenses over 15 years in 41 countries. #VaccinesWork #ProtectedTogether  @Gavi @VoICE_Evidence http://bit.ly/2UFZQCo

Infographic

Tweet 4b

Spend $1 on vaccines for the developing world and get a 16X return! Health & Wealth #ProtectedTogether thanks to #VaccinesWork. #VaccinesWork @VoICE_Evidence @Gavi http://bit.ly/2G6oJO2

infographic

Tweet 4c

$544Billion in productivity losses and medical treatment costs averted in 73 Gavi countries thanks to vaccines. Health and wealth #ProtectedTogether! #VaccinesWork @VoICE_Evidence  http://bit.ly/2P22Xz2

#ProtectedTogether: Strengthening health systems

Tweet 5a

Vaccines keep health systems healthy by preventing costly infections. #ProtectedTogether #VaccinesWork @VoICE_Evidence http://bit.ly/2P22Xz2

Tweet 5b

#ProtectedTogether: In Kenya, rates of pneumonia hospitalizations in children <5 dropped by 27% after 4 years of PCV10. #VaccinesWork to reduce hospital admissions and free up more resources to treat and prevent other illnesses @VoICE_evidence https://bit.ly/2Im0xfk

VIDEO INSERT HERE: https://www.dropbox.com/s/7z94hnzefdto2qk/Tweet%205b_PCV%20Hospitalizations.mp4?dl=0

Tweet 5c

Bangladesh: no hospital bed available for 1 in 4 sick kids. Vaccines keep kids out of hospitals. Healthy kids, healthy health systems #ProtectedTogether #VaccinesWork @VoICE_Evidence http://bit.ly/2Uvqf6w

Tweet 5d

Keeping kids healthy with rotavirus vaccines eases the burden on hospitals and frees up resources for other patients. Health systems and children stay #ProtectedTogether #VaccinesWork @VoICE_Evidence http://bit.ly/2X09v4b

VIDEO INSERT HERE: https://www.dropbox.com/s/a5w0kxk034nkuog/Tweet%205d_Rota%20Hospitalizations.mp4?dl=0

Critical but complex: Vaccination during conflict and forced migration

Camp de réfugiés en situation d'urgence humanitaire à Cox's Bazar, représentant des tentes, des maisons de fortune et des réfugiés

Conflict and forced migration – resulting in disruption of communities and health systems – amplify the risk factors for infectious disease and increase the urgency of preventive measures such as immunization. While disease outbreaks of measles, cholera, meningitis and even polio in refugee camps may be the most widely covered issues related to immunization in conflict-affected areas and populations, this VoICE Featured Issue explores some of the less-visible, but equally critical aspects. Immunizations play an important role in these settings, considering the threat of malnutrition and antimicrobial resistance, economic pressures, and the urgent need for responsive policies.

A selection of VoICE evidence in this issue

Close, R.M., Pearson, C., Cohn J. 2016. Vaccine-preventable disease and the under-utilization of immunizations in complex humanitarian emergencies.. Vaccine. 34(39).

Teleb N. and Hajjej R. 2017. Vaccine preventable diseases and immunization during humanitarian emergencies: challenges and lessons learned from the Eastern Mediterranean Region. East Mediterr Health J.. 22(11).

Gargano L.M., Hajjeh R., and Cookson S.T. 2017. Pneumonia prevention: Cost-effectiveness analyses of two vaccines among refugee children aged under two years, Haemophilus influenzae type b-containing and pneumococcal conjugate vaccines, during a humanitarian emergency, Yida camp, South Sudan. Vaccine. 35(3).

Von Gottberg, A., de Gouveia, L., Tempia, S., et al. 2014. Effects of pneumococcal vaccine in invasive pneumococcal disease in South Africa. New England Journal of Medicine. 371(20).

Dagan, R., Sikuler-Cohen, M., Zamir, O., et al 2001. Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees. Pediatric Infectious Disease Journal. 20(10).

Fireman, B., Black, S.B., Shinefield, H.R., et al. 2003. Impact of pneumococcal conjugate vaccine on otitis media. Pediatric Infectious Disease Journal. 22(1).

Centers for Disease Control and Prevention 2013. Antibiotic resistance threats in the United States, 2013 (Report).

Gargano L.M., Hajjeh R., and Cookson S.T. 2015. Pneumonia prevention during a humanitarian emergency: Cost-effectiveness of Haemophilus Influenzae Type B conjugate vaccine and pneumococcal conjugate vaccine in Somalia. Prehospital and Disaster Medicine. 30(4).

Kadir, A., Shenoda, S., Goldhagen, J., et al. 2018. The Effects of Armed Conflict on Children. Pediatrics. 142(6).

Nellums, L.B., Thomson, H., Castro-Sanchez, E. et al. 2018. Antimicrobial resistance among migrants in Europe: systematic review and meta-analysis.. Lancet Infectious Disease. 18(7).

Gargano, L. M., Tate, J. E., Parashar, U. D., et al. 2015. Comparison of impact and cost-effectiveness of rotavirus supplementary and routine immunization in a complex humanitarian emergency, Somali case study.. Conflict and health. 9(5).

Key Points:

  1. Malnutrition and infectious disease – together set off a dangerous and potentially life-threatening cycle – represent the greatest twin threat to health during humanitarian emergencies. Vaccines can help interrupt the cycle and mitigate some of the risk to refugees and conflict-affected populations.
  2. The spread of antimicrobial resistant organisms and infections may be increased in the conditions present in areas experiencing conflict and significant population displacement.
  3. The provision of immunizations to refugees can be cost-effective and may avert significant treatment-related expenses from infections down the road.
  4. Preparing for emergencies, especially at the policy level, is a critical success factor for countries affected by humanitarian crises and those hosting displaced populations.
CalloutBox

Exhausted, hungry, not sure where they will sleep or bathe, or for how long they may have to stay in a makeshift camp…displaced people arriving in refugee camps are often stepping into a perfect storm of risk factors for poor health and vaccine-preventable infections. Exhaustion, malnutrition and poor access to clean water and sanitation all contribute to increasing a person’s risk of infectious disease. Having taken only what they could carry, these people are also living in poverty (some are newly poor, having abandoned possessions and property to flee the fighting), which is a well-known risk factor for developing vaccine-preventable diseases and further impoverishment. A scene like this only hints at the long list of health risks and challenges facing refugees fleeing from, and families living in, conflict-ridden zones.

Figure 1: The domino effect of humanitarian emergencies and infectious disease

Conflict and forced migration – resulting in disruption of communities and health systems – amplify the risk factors for infectious disease and increase the urgency of preventive measures such as immunization. While disease outbreaks of measles, cholera, meningitis and even polio in refugee camps may be the most widely covered issue related to immunization in conflict-affected areas and populations, in this VoICE Featured Issue we will explore some of the less visible, but equally critical aspects of immunization in these settings including malnutrition, antimicrobial resistance, economics and policy.

Malnutrition and infectious disease

Figure 1 illustrates the domino effect of conflict and other complex humanitarian emergencies on health, in particular nutrition and risk of infectious disease. Ultimately, malnutrition and infectious diseases are significantly worsened in such situations and are responsible for a majority of deaths, even far outstripping trauma and violent injuries due to fighting in areas of active combat, according to a 2011 Technical Report from the World Bank. In a recent Technical Report in the journal Pediatrics, researchers noted that children under 5 years of age bear the greatest burden of indirect conflict-associated mortality, largely due to disruptions in health services, such as vaccination, and access to food.

Several studies have concluded that respiratory and gastrointestinal infections are the two leading causes of death during complex humanitarian emergencies (CHEs) “…independent of geography, time and crisis-type…”, according to a recent review. The authors of this review go on to say, given the close cyclical relationship between infectious diseases and malnutrition, immunization could help defend people against the infectious disease risks that come with malnutrition, a problem which is exceedingly common in humanitarian crises. Pneumococcal, Hib, measles, rotavirus and cholera vaccines can help protect populations who are especially vulnerable to malnutrition .

For more on the nutrition and disease cycle, see our VoICE Featured Issue on the links between malnutrition and infectious disease.

Antimicrobial resistance in refugee settings

Antimicrobial resistance – or the ability of some bacteria to survive treatment with antibiotics – is another heavy burden that rests on those living in and fleeing from conflict zones. A 2018 systematic review found that a quarter of migrants who fled to the European region either carried or were infected with antimicrobial resistant organisms, and that this rate rose to a third of all refugees or asylum seekers.[1] Contributing factors include crowded living conditions with variable access to sanitation, poor overall health, lack of access to vaccines, as well as the exposure to new pathogens stemming from the mingling of large numbers of people originating from geographically distinct areas.

Availability of treatment and other health services in areas of conflict or in newly established refugee camps may be very low, and treatment for antibiotic resistant infections can be particularly difficult and costly, even in well-resourced health systems.

A large review of the use of vaccines in complex humanitarian emergencies stated that the reduction of antimicrobial resistance was an important indirect effect of the use of vaccines in such settings. Immunization helps curb the spread of antimicrobial resistant organisms by preventing infections that might otherwise be treated with antibiotics, thereby decreasing opportunities for the development of resistance. Not only do vaccines decrease the use of antibiotics, but they prevent occurrence of resistant infections. Use of the pneumococcal conjugate vaccine in South Africa has led to significant declines in invasive pneumococcal disease cases caused by bacteria that are resistant to one or more antibiotics. In fact, the rate of infections resistant to two different antibiotics declined nearly twice as much as infections that could be treated with antibiotics.

The economics of immunization and conflict

The conditions present in refugee settings are both logistically challenging – with potentially large numbers of people moving in and out, lack of health records, sanitation, supplies, etc. – and ripe for infectious diseases and outbreaks. These factors make it very difficult to provide enough emergency health and treatment services during emergencies, and such services take time and significant expense to establish. Although delivering vaccines in these settings is not without difficulty, the ability of immunization to prevent illness and disease spread, and to protect malnourished populations carries economic benefits.

Evidence from recent humanitarian crises in Somalia and South Sudan has shown vaccination against Hib and pneumococcal pneumonia would be cost-effective and could reduce pneumonia cases and deaths by nearly 20%. Similarly, researchers conclude that the use of the rotavirus vaccine to reduce diarrheal disease and deaths in Somalia, during its ongoing civil conflict would be cost-effective, even in the face of vaccine delivery challenges.

Where do we go from here?

The number of armed conflicts and forced displacements worldwide is at an all-time high. The majority of people displaced by conflict and other humanitarian emergencies are either internally displaced (within the borders of their country of origin) or flee to neighboring countries. This has led to the greatest burden of care for refugees being placed on developing countries who may themselves be struggling – both economically and programmatically, in terms of the delivery of health services such as immunization.

In the map in Figure 2 below you can see countries with active armed conflict in 2015, marked with a black star, overlaid on a map of the coverage of one dose of measles-containing vaccine – for which the WHO says 90% coverage is needed to avert disease outbreaks – during the preceding year (2014). Although it is not surprising that countries afflicted by conflict are also struggling to achieve high vaccine coverage, it is a reminder that political and health system fragility go hand-in-hand and that these fragile countries are also those most often called upon to help neighbors in crisis.

Figure 2: Armed conflict and low vaccine coverage often occur in the same places.

Coverage of one dose of measles-containing vaccine in countries affected by armed conflict.
Measles coverage map: World Health Organization. WHO/UNICEF coverage estimates. Available at http://www.who.int/immunization/monitoring_surveillance/en 
Armed conflict overlay: Adapted from: Kadir A, Shenoda S, Goldhagen J, et al. The Effects of Armed Conflict on Children. Pediatrics. 2018;142(6)

There have been some notable success stories, for example in Yemen and the Syrian Arab Republic, where vaccination coverage has largely been sustained and is credited with averting a potentially significant burden of preventable infection. Credit for this success is due to the establishment of emergency preparedness procedures and policies in advance of crises and through coordinated programmatic and financial support from governments and partners such as the World Health Organization, UNICEF and non-governmental organizations. Thanks to the readiness of such partners, in October 2018, WHO and UNICEF succeeded in vaccinating more than 300,000 people in Yemen against cholera during a 4-day ceasefire.

The establishment of national policies addressing the health of refugees and migrants is essential step, and challenges abound in both developing and developed nations. In Bangladesh, an engaged health sector, quick government response and an existing multi-sector action plan for disease outbreaks in Bangladesh have been responsible for a robust and ongoing response to vaccine-preventable infections and very low vaccination coverage among Rohingya refugees arriving from Myanmar. In the European region, where more than 30% of the global migrant population resides, only one-third of countries had established policies for the immunization of migrants and refugees. In countries without such policies, many migrants and refugees miss out on vaccinations – either because it is unclear to providers who can be vaccinated and who pays, or because families are not made aware of the mechanisms or opportunities around vaccination.

Humanitarian crises and population displacement are not going away. Limiting the damage to the health of people in crisis will require the swift and broad use of health interventions such as vaccination, policies that help plan for the worst and engaged partners. Best stated by Peter Salama, head of the WHO’s Emergency Response division, “What we really need is international solidarity.”

[1] It is important to note that the greatest risk of AMR related to population displacement is to the displaced themselves. A report released by the World Health Organization last month on the health of refugees and migrants in the European region[1] notes that transmission of antimicrobial resistant infections almost exclusively affects those residing in refugee transit centers and settlements and does not pose an immediate threat to host populations.

For Additional Information:

 To learn more about the relationship between immunization and conflict, migration and complex humanitarian emergencies, see related messages and evidence in the VoICE tool found here: https://immunizationevidence.org/search-immunization-evidence/?fwp_topic=conflict-and-humanitarian-emergencies

World Health Organization, Report on the health of refugees and migrants in the WHO European Region. No PUBLIC HEALTH without REFUGEE and MIGRANT HEALTH; 2018; Geneva, Switzerland.  Found here: http://www.euro.who.int/en/publications/abstracts/report-on-the-health-of-refugees-and-migrants-in-the-who-european-region-no-public-health-without-refugee-and-migrant-health-2018

World Bank. World Development Report 2011 Background Paper, Demographic and Health Consequences of Civil Conflict. 2011. Found here: https://openknowledge.worldbank.org/bitstream/handle/10986/9083/WDR2011_0011.pdf?sequence=1&isAllowed=y

Universal Health Coverage: What immunization advocates should consider

December 12th is worldwide Universal Health Coverage (UHC) day! Although exceedingly complex in its implementation, the concept behind UHC is simple: All people should benefit from quality health services, medicines and vaccinations, and no one should be put in financial peril to do so. In recognition of UHC Day 2018, the VoICE team brings you a brief look at the interplay between coverage of immunization and other basic health interventions, and the important role of immunization in protecting against financial risk – both within the context of the Sustainable Development Goal Target for UHC.

A selection of VoICE evidence in this issue

Hinman, A.R., and McKinlay, M.A. 2015. Immunization equity. Vaccine. 33(2015).

Chebab, E.T., et al. 2016. Experience of integrating vitamin A supplementation into polio campaigns in the African Region.. Vaccine. 34(43).

Torres-Rueda, S., Rulisa, S., Burchett, H.E., et al. 2016. HPV vaccine introduction in Rwanda: Impacts on the broader health system. Sexual and Reproductive Healthcare. 7.

Niessen, L., ten Hove, A., Hilderink, H., et al 2009. Comparative impact assessment of child pneumonia interventions. Bulletin of the World Health Organization. 87.

Deoganakar, R., Hutubessy, R., van der Putten, I., et al 2012. Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries. BMC Public Health. 12(878).

Olusanya, B.O. 2009. Optimising the use of routine immunisation clinics for early childhood development in sub-Saharan Africa. Vaccine. 27.

Restrepo-Mendez, M.C., Barros, A.J., Wong, K.L.M., et al. 2016. Missed opportunities in full immunization coverage: findings from low- and lower-middle-income countries. Global Health Action. 9(1).

Verguet, S., Memirie, S.T., and Norheim, O.F. 2016. Assessing the burden of medical impoverishment by cause: a systematic breakdown by disease in Ethiopia. BMC Medicine. 14(1).

Chang, A.Y., Riumallo-Herl, C., Perales, N.A., et al. 2018. The equity impact vaccines may have on averting deaths and medical impoverishment in developing countries. Health Affairs. 37(2).

Key Points 

  1. Achieving universal coverage of basic health services will require strengthening and expanding current health systems AND new approaches to reaching those who still cannot or do not access health services.
  2. The reach of immunization delivery programs can be leveraged to provide other basic services – and increase financial efficiency of health systems – and the reverse is also true: the delivery of other interventions can help to increase the uptake of vaccines.
  3. Achievement of UHC will positively contribute to at least six of the 17 Sustainable Development Goals.
  4. Immunization can contribute significantly to achieving financial risk protection against health costs.

Universal Health Coverage and the Sustainable Development Goals

December 12th is worldwide Universal Health Coverage (UHC) day!  The aim of drawing attention to this day is to shine the global spotlight on the gaps in achieving health as a human right. Although exceedingly complex in its implementation, the concept behind UHC is simple: All people should benefit from quality health services, medicines and vaccinations, and no one should be put in financial peril to do so.

In 2015, 193 United Nations Member States committed to an ambitious set of 17 “Sustainable Development Goals” (SDGs) by 2030. The right to health not only figures prominently as a goal in and of itself – SDG3 is to “Ensure healthy lives and promote well-being for all at all ages” – but is also fundamentally intertwined with goals related to equity, poverty, economic growth and inclusion. (See Figure 1.)

Figure 1: The interrelatedness of Universal Health Coverage with other Sustainable Development Goals, and the importance of health systems strengthening.

Source: Tracking Universal Health Coverage: 2017 Global Monitoring Report. World Health Organization and International Bank for Reconstruction and Development / The World Bank; 2017. License: CC BY-NC-SA 3.0 IGO. Available here: http://www.who.int/healthinfo/universal_health_coverage/report/2017/en/

Embodied in the 8th Target of  SDG3 (SDG 3.8), the pursuit of UHC is supported by the twin indicators of 1) coverage of essential services (including immunization), and 2) financial risk protection from the incurrence of economically burdensome health costs.  In recognition of UHC Day 2018, the VoICE team brings you a brief look at the interplay between coverage of immunization and other basic health interventions, and the important role of immunization in protecting against financial risk – both within the context of SDG 3.8.

Building on coverage of vaccines gives UHC a head start, but there is more to do

Equity is at the heart of the Sustainable Development Goal target 3.8, which seeks to achieve universal health coverage and financial risk protection for all.  The coverage indicator for the achievement of UHC tracks the coverage of 14 “tracer interventions”, which together serve as a barometer for access to basic health services. Access to immunization is tracked through the coverage of the third dose of DTP3, one of four maternal and child health tracer interventions. Although DTP3 coverage is evidence of the fact that immunization is one of the most widely available and equitably distributed interventions worldwide, several other important vaccines lag behind the 85% coverage of DTP3 worldwide in 2017.

Specific vaccines notwithstanding, high coverage with some vaccines such as DTP make immunization programs a critical backbone of any universal health coverage strategy. Routine and campaign-based immunization programs reach some children in remote or poverty stricken areas whose families have little other connection to the health system, and as such, offer opportunities to provide additional basic health care services to children and their families, especially interventions associated with maternal and child health. See Figure 2 for some highlights from VoICE of the opportunities for mutual reinforcement between immunization and other programs.

Figure 2: Examples of the integration of immunization and other health services.

Vitamin A distribution integrated with polio vaccine campaigns led to increased VitA coverage in several African countries.

Delivery of HPV vaccine to school-age girls in Rwanda provided an opportunity to offer school-age boys a variety of health services at the same time.

The timing of childhood immunizations could be harnessed to deliver a range of early childhood development interventions such as newborn hearing screening, sickle cell screening, treatment and surveillance, maternal education around key newborn care issues such as jaundice, and tracking early signs of poor growth and nutrition.

Despite the relatively high coverage globally of some vaccines, other critical vaccines have reached only a small fraction of the world’s children. Fully 15% of the world’s children are not reached at all by immunization – a gap whose distribution carries significant inequity – so vaccine coverage successes are very much tied to the achievement of UHC goals and targets for other health services.

The achievement of UHC targets will, however, require significant reform and expansion of existing health systems to address challenges such as missed opportunities to integrate services. For example, a recent study in 14 low- and middle-income countries found an exceedingly high rate of missed opportunities to vaccinate in 8 of the 14 countries, despite families coming into contact with the health system. For these countries, children failed to be vaccinated more than 50% of the time, despite they or their mother having received at least one of 5 other basic health interventions provided through the health system. Additionally, for the millions of families not reached at all by current health systems, barriers may include socio-cultural factors, in addition to geography, education, poverty, etc.

For these families and others with inadequate health services, a truly equity-driven approach is needed. That is, governments, partners, health-providers, and systems will need find ways to provide whatever additional support is needed to help them catch up, not just make the same resources available to everyone.

For families, financial barriers to immunization are relatively low, but health and economic returns are high

The second indicator of the universal health coverage target acknowledges that the costs associated with health care – both preventative services and treatment for illness – are a significant barrier for hundreds of millions of people around the world. These costs prevent some people from even trying to access health services, and for those who do seek care they cannot afford, the financial burden of these services can have significant, negative and lasting economic impact. The provision of a basic package of preventative services, including immunization, would thus create a positive, reinforcing cycle of increased health-seeking behavior and improved financial stability for individuals, families and economies.

Immunization is a critical element to success for two reasons. First, thanks to global institutions such as Gavi and UNICEF, immunization is free of charge for a large proportion of families in the world’s middle and low-income nations and financial barriers to access are thus relatively low. However, not all crucial vaccines are yet available through national immunization programs in every country. In some places, lifesaving vaccines against disease such as pneumococcal disease are only available through the private market, carrying a price tag far too high for many families to access. And, as mentioned above, sociocultural factors and other issues are significant drivers of gaps in vaccine coverage and these must be addressed carefully and concertedly.

The second reason immunization is critical to meeting the financial risk protection targets of UHC is much more obvious: the widespread use of vaccines has the power to avert significant costs associated with treatment of infections. The huge economic burden of these infections stems from the costs associated with treating relatively low-cost but frequently occurring infections and complicated infections such as meningitis which are rare but very expensive to treat. These vaccine-preventable episodes of illness are responsible for a large number of families being pushed into poverty each year.

Visit the VoICE tool to find out more about how vaccines can help people avoid economic impoverishment from medical costs. Read our feature on medical impoverishment averted through immunization in 41 low-income nations.

A mother holding her child that is receiving a vaccine.

The hurdles that remain are high, but health for all awaits on the other side

The road to UHC will be fraught with risk and will require creative new ideas for reaching the unreached. For one, we must ensure that whatever systems are put in place to expand access to basic health interventions will not inadvertently damage immunization coverage, but will reinforce progress that has been made in expanding immunization coverage.

It is also clear that the achievement of UHC goals by 2030, or by any time, will require us to not only expand and improve upon the health systems that already exist, but also to change our approach to these imperfect health systems. Those families who receive no basic health services are called “hard to reach” for a reason. The challenge in devising a system flexible and comprehensive enough to reach everyone is very real, and very worthwhile.

The Unyielding Impact of Childhood Diarrhea

Infographic

Despite tremendous global progress, diarrhea remains the second leading infectious cause of under-5 deaths, taking a child’s life almost every minute. Although diarrhea can seem like a common, simple childhood ailment in many places, a single episode of diarrhea can be serious, even deadly, and have severe economic implications for families and communities. Advocates play a critical role in ensuring evidence-based diarrhea prevention and control programs and policies are a top priority globally and in the countries where this disease is most prolific.

A selection of VoICE evidence in this issue

Chai, P.F., and Lee W. S. 2009. Out-of-pocket costs associated with rotavirus gastroenteritis requiring hospitalization in Malaysia. Vaccine. 27(5).

DeBoer, M.D., Chen, D., Burt, D.R. et al 2013. Early childhood diarrhea and cardiometabolic risk factors in adulthood: The Institute of Nutrition of Central America and Panama (INCAP) Nutritional Supplementation Longitudinal Study. Annals of Epidemiology. 23(6).

Loganathan, T., Lee, W.S., Lee, K.F., et al 2015. Household Catastrophic Healthcare Expenditure and Impoverishment Due to Rotavirus Gastroenteritis Requiring Hospitalization in Malaysia. PLOS One. 10(5).

Saha, S., Santosham, M., Hussain, M. et al. 2018. Rotavirus Vaccine will Improve Child Survival by More than Just Preventing Diarrhea: Evidence from Bangladesh. American Journal of Tropical Medicine and Hygiene. 98(2).

Riumallo-Herl, C., Chang, A.Y., Clark, S., et al. 2018. Poverty reduction and equity benefits of introducing or scaling up measles, rotavirus, and pneumococcal vaccines in low-income and middle-income countries: a modeling study. British Journal of Medicine Global Health. 3:e000612.

Burnett, E., Jonesteller, C. L., Tate, J. E., et al. 2017. Global impact of rotavirus vaccination on childhood hospitalizations and mortality from diarrhea.. The Journal of Infectious Diseases. 215(11).

Hendrix, N., Bar-Zeev, N., Atherly, D., et al 2017. The economic impact of childhood acute gastroenteritis on Malawian families and the healthcare system. BMJ open. 7(9).

Schlaudecker, E.P., Steinhoff, M.C. and Moore, S.R. 2011. Interactions of diarrhea, pneumonia, and malnutrition in childhood: recent evidence from developing countries. Current Opinion in Infectious Diseases. 24(5).

How preventing diarrhea can protect children, families, communities, and health systems

Despite tremendous global progress, diarrhea remains the second leading infectious cause of under-5 deaths, taking a child’s life almost every minute.[1],[2] Although diarrhea can seem like a common, simple childhood ailment, in many places a single episode of diarrhea can be serious, even deadly, and have severe economic implications for families and communities.

  • Repeated, prolonged diarrhea can have lasting – but sometimes overlooked – impacts on child health and development.
  • Treating diarrhea can be costly to families and health systems, and treatment costs can even push some families into poverty.
  • Rotavirus causes approximately one third of diarrhea deaths, and is only adequately preventable via vaccination – water, sanitation, and hygiene interventions that work to prevent other types of diarrhea don’t work to prevent rotavirus.
  • Cholera vaccination is used to stop endemic cholera and respond to cholera outbreaks, which are common in humanitarian emergency settings.

Advocates play a critical role in ensuring evidence-based diarrhea prevention and control programs and policies are a top priority globally and in the countries where the outcomes of diarrheal diseases are most devastating.

The burden of diarrhea globally

Each year, there are an estimated 1 billion episodes of diarrhea with approximately 500,000 deaths in children under five years of age.[1],[2] WHO estimates that children in low- and middle-income countries each have approximately three episodes of diarrhea a year.[3]  Although improvements have been made in our efforts to stop diarrhea deaths, we still have far too many episodes: since 1990, the number of diarrhea deaths has decreased by 65%, but the number of new diarrhea episodes has decreased by only 24%.[4] This burden is disproportionally concentrated in low- and middle-income countries, with over half of the diarrheal deaths occurring in sub-Saharan Africa – a low-resource setting where progress is slowest.[5]

The impact of diarrhea on children

Each episode of diarrhea deprives a child of nutrition necessary for growth and contributes to malnutrition, making these children more vulnerable to diarrhea yet less able to fight it.[3] After an episode of diarrhea, children grow less in length than children who did not have diarrhea.  When a child has repeated episodes of diarrhea, it can lead to chronic malnutrition and stunting, which in turn is associated with poor functional outcomes such as impaired cognitive development. Prolonged and frequent episodes of diarrhea in young children under the age of two affects them in later childhood and adolescence by leading to delays in school readiness and poor performance in school, as compared to their peers.

Episodes of diarrhea can exacerbate underlying undernutrition and can impair immunity hampering the ability to fight diseases such as pneumonia.[6] During diarrheal episodes, children can lose Vitamin A and zinc, which may predispose some children to pneumonia. In addition, children with more frequent episodes of diarrhea are more likely have chronic health issues later in life, like high blood pressure, which are taxing on both families and health systems.

Tools to defeat diarrhea

Aids to Help Protect and Prevent diarrhea disease and deaths

We have highly effective tools to fight diarrhea. Interventions to improve water, sanitation, and hygiene (WASH) have been successful in reducing the number of diarrhea cases.[7]  Exclusive breastfeeding for the first 6 months of life can protect infants from undernutrition and its associated vulnerability to diarrhea.[7] Inexpensive but effective treatments like oral rehydration salts (ORS) and zinc supplements work to stop diarrhea episodes from becoming severe and deadly. Yet, access to ORS and zinc is dismally low in many high-burden settings. In 6 of the 10 countries with the highest number of diarrhea deaths[7], national ORS coverage is below 40%.[8] In half of the 10 highest-burden countries[7], fewer than one in ten children have access to zinc supplements. In addition, we also see inequities in access to treatment. In at least half of the 10 highest-burden countries, ORS coverage was at least 10 percentage points lower in rural areas compared to urban areas, or in the poorest 20% of the population compared to the wealthiest 20%.[8]

Infographic

Vaccination is our strongest protection against vaccine-preventable causes of diarrhea

Two types of common diarrhea are vaccine preventable: rotavirus and cholera. Rotavirus vaccines are especially crucial in preventing a large proportion of diarrhea deaths and hospitalizations around the world. Cholera vaccination is critical in preventing outbreaks in high-risk settings.

 Rotavirus vaccination can prevent hospitalizations and death

Although WASH interventions have successfully reduced the global burden of diarrhea, one main cause of diarrhea mortality – rotavirus – is not prevented through WASH interventions.[9],[10] Rotavirus is associated with approximately one third of diarrhea deaths and can only be adequately prevented through vaccination.[2],[9]

Rotavirus is a leading cause of diarrhea in infants.[5] This highly contagious virus kills about 200,000 children under 5 each year and is responsible for almost 40% of all diarrhea hospitalizations each year.[2],[5] Although ORS can treat simple cases of rotavirus, many of the world’s poorest children don’t have access to ORS.[8] Rotavirus vaccines have proven highly effective and impactful in countries where they have been introduced. In Malawi, for example, there was a 35% decrease in all-cause diarrhea deaths following rotavirus vaccination.[11] Rotavirus hospitalizations in children under 1 year fell by 80% after vaccine introduction.[12] As of January 2019, 97 countries have introduced rotavirus vaccines into their national schedule.[13] 

Current Rotavirus Vaccine Introduction Status*

Map of Current Rotavirus Vaccine Introduction Status
*As of January 2019

Rotavirus vaccination can protect health systems and resources 

Although diarrhea treatment is relatively inexpensive, when we factor in the sheer burden of diarrhea, these treatments are costly to health systems and require substantial health worker capacity.  Although many cases of diarrhea can be treated in outpatient facilities with low-cost treatment, inpatient treatment of diarrhea can cost hospitals 25 times the cost of outpatient treatment, per patient.[14]

Treating diarrhea uses limited health systems resources, such as hospital beds, and consequently consumes the resources that can be used to treat other diseases – often diseases aren’t preventable. Therefore, direct and indirect benefits of rotavirus vaccination programs play a critical role in reducing the strain on health systems. One in four children who were taken to a large pediatric hospital in Bangladesh were refused admission to the hospital because all of the beds were occupied. Acute diarrhea was one of the most common reasons for being admitted to the hospital, showing children with acute diarrhea filled many of the available hospital beds. Over half of the acute diarrhea cases that were admitted were due to rotavirus, showing that vaccination could prevent children from both needing and utilizing essential hospital resources.

We’ve seen tremendous reductions in hospitalizations for rotavirus diarrhea and all-cause diarrhea following rotavirus vaccine introductions.[15] A review of rotavirus vaccine introductions found that, globally, all-cause diarrhea hospitalizations reduced by almost 40% in children under 5 in regions where the vaccine had been introduced. The continued use and scale up of rotavirus vaccines will alleviate pressure from over-burdened facilities, enabling health systems to be more responsive.

Rotavirus vaccination may protect families from being pushed into poverty due to treatment costs

Rotavirus vaccination programs can protect the most vulnerable families from medical impoverishment and catastrophic healthcare costs. When looking at all-cause diarrhea In Malawi, the costs associated with treating diarrhea pushed families into poverty, with treatment costs exceeding the monthly income for one in six families needing inpatient care and one in ten families needing outpatient care. Families can be pushed into poverty by the costs of hospitalizing a child with rotavirus for several days. In Malaysia, the inpatient costs of rotavirus treatment can cost families 25% of an average family’s monthly income. Direct and indirect treatment costs, such as medicine and transportation, caused almost 9 in 10 Malaysian families to spend more than 10% of their monthly household income on treating rotavirus.

Rotavirus vaccine introduction in 41 GAVI-eligible countries could avert 40% of catastrophic health costs – 900,000 cases – and 40% of medical impoverishment – 200,000 cases. In other words, with rotavirus vaccination programs, 900,000 families would not incur health costs that are higher than a substantial proportion of their income and 200,000 families not would fall below the poverty line due to treatment costs. If rotavirus vaccination programs were introduced or scaled up in Gavi-supported countries, $200 million in out-of-pocket health expenses attributable to severe rotavirus infections could be averted, meaning low-income families would have more disposable income and greater financial stability. With vaccines being one of the more equitable health interventions accessible to poor families, they are an important strategy to reduce the gap in health outcomes by household income as well as protect many families from being pushed into poverty. Inequitable access to treatment, not an uncommon event, only exacerbates the disproportionate risk of mortality in vulnerable children, again underscoring the importance of preventing diarrhea in the first place and protecting children from the vicious aftermath of diarrhea.

Rotavirus vaccination can protect communities

Rotavirus vaccines provide immunity for not only children directly vaccinated but also affords protection to their families and communities. This herd immunity magnifies the public health benefit of rotavirus vaccination by extending protection to those age groups in the population who are not directly receiving the vaccine but can contract and transmit the disease. This additional benefit is essential for a resilient pathogen like rotavirus, that can live on surfaces – and therefore transmit disease – for days. As a result of rotavirus immunized children in the community, rotavirus hospital admissions in unvaccinated children aged two to five years of age, who were not age-eligible to receive the vaccine at the time, were reduced by 41% to 92% in hospitals across the US, showing the profound value of herd immunity.

Baby receiving vaccine

Cholera vaccination can protect vulnerable groups

Cholera burden

Diarrhea caused by cholera can be rapidly fatal, with as many as 1 in every 5 cases of cholera advances to severe disease.[16] Cholera, often called a disease of poverty, can be endemic and epidemic in settings without strong water and sanitation systems, such as humanitarian emergency settings. Because settings where cholera is most rampant are often those with weak or overburdened health systems, diagnosing and recording cases is difficult; the global estimates of cholera cases each year – between 1.3 and 4 million cases – likely underestimate the true burden.[16]

Unlike many vaccine-preventable diseases, the global number of cholera cases has been steadily climbing for the past 10 years. Devastating cholera epidemics have impacted Yemen, Haiti, Somalia, the Democratic Republic of Congo, and South Sudan in recent years, and continue to be a threat in fragile settings.[17] In addition to the health impacts of cholera, previous outbreaks have led to significant economic losses to countries, caused by reduced revenue on trade and tourism, and continue to threaten countries.[16]

Cholera vaccination

 Cholera vaccination is a crucial, cost-effective tool to fight cholera, especially in fragile settings that lack sufficient water and sanitation. In 2013, global partners collaborated to form a stockpile of the oral cholera vaccine, managed by the Global Task Force on Cholera Control and funded by Gavi, the Vaccine Alliance.[16] The stockpile has been utilized for mass vaccination campaigns for prevention in humanitarian crises and for reactive response to outbreaks.[17]

An important – and beneficial – feature of cholera is that vaccinating a relatively small number of people can result in significant herd protection. Research from Bangladesh suggests that 70% vaccine coverage can stop cholera transmission, which greatly amplifies the impact of vaccine campaigns and investments.[18] Cholera vaccination is also a critical tool in managing outbreaks and protecting national and global health security.

Continuing – and strengthening – the fight against diarrheal diseases

Certain types of serious diarrhea can be both preventable and treatable, and a large proportion of child diarrhea deaths can be prevented through vaccination. We have the tools to defeat diarrhea, but these tools are only effective when backed by strong political and financial commitment. The global fight against childhood diarrhea has undoubtedly had a profound impact on child health and broader societal development. Yet, consistently low treatment coverage and constraints in vaccine supply highlight ongoing challenges. These challenges must be responded to with the resources and commitment necessary to pick up the pace of progress, so we can be stronger in the global fight against one of the most common causes of childhood illness and death.

[1] WHO and Maternal and Child Epidemiology Estimation Group, Estimates of child cause of death, diarrhoea 2018. Retrieved from: https://data.unicef.org/topic/child-health/diarrhoeal-disease/

[2] Institute for Health Metrics and Evaluation (2018). Global burden of disease, GBD Results tool. Retrieved from: http://ghdx.healthdata.org/gbd-results-tool

[3] World Health Organization (2017).  Diarrheal Disease. Retrieved from: http://www.who.int/en/news-room/fact-sheets/detail/diarrhoeal-disease

[4] Troeger, C., Colombara, D. V., Rao, P. C., Khalil, I. A., Brown, A., Brewer, T. G., … & Petri, W. A. (2018). Global disability-adjusted life-year estimates of long-term health burden and undernutrition attributable to diarrhoeal diseases in children younger than 5 years. The Lancet Global Health, 6(3), e255-e269.

[5] Tate, J. E., Burton, A. H., Boschi-Pinto, C., Parashar, U. D., World Health Organization–Coordinated Global Rotavirus Surveillance Network, Agocs, M., … & Ranjan Wijesinghe, P. (2016). Global, regional, and national estimates of rotavirus mortality in children< 5 years of age, 2000–2013. Clinical Infectious Diseases62(suppl_2), S96-S105.

[6] Ibrahim, M. K., Zambruni, M., Melby, C. L., & Melby, P. C. (2017). Impact of childhood malnutrition on host defense and infection. Clinical microbiology reviews, 30(4), 919-971.

[7] WHO/UNICEF (2013). Ending preventable child deaths from pneumonia and diarrhoea by 2025: The integrated Global Action Plan for Pneumonia and Diarrhoea (GAPPD). Retreieved from: https://www.who.int/maternal_child_adolescent/documents/global_action_plan_pneumonia_diarrhoea/en/

[8] International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. (2018). Pneumonia and Diarrhea Progress Report 2018.

[9] Lamberti, L. M., Ashraf, S., Walker, C. L. F., & Black, R. E. (2016). A systematic review of the effect of rotavirus vaccination on diarrhea outcomes among children younger than 5 years. The Pediatric infectious disease journal, 35(9), 992-998.

[10] Glass, R. I., Parashar, U., Patel, M., Gentsch, J., & Jiang, B. (2014). Rotavirus vaccines: successes and challenges. Journal of infection, 68, S9-S18.

[11] Bar-Zeev, N., King, C., Phiri, T., Beard, J., Mvula, H., Crampin, A. C., … & Costello, A. (2018). Impact of monovalent rotavirus vaccine on diarrhoea-associated post-neonatal infant mortality in rural communities in Malawi: a population-based birth cohort study. The Lancet Global Health, 6(9), e1036-e1044.

[12] Burnett, E., Jonesteller, C. L., Tate, J. E., et al. 2017. Global impact of rotavirus vaccination on childhood hospitalizations and mortality from diarrhea.. The Journal of Infectious Diseases. 215(11), 1666-1672..

[13] International Vaccine Access Center (2018). VIEW-hub: Vaccine Introduction and Epidemiology Window. Retreived from: http://view-hub.org. Accessed January 31, 2018.

[14] Sarker, A. R., Sultana, M., Mahumud, R. A., Ali, N., Huda, T. M., Haider, S., … & Morton, A. (2018). Economic costs of hospitalized diarrheal disease in Bangladesh: a societal perspective. Global health research and policy, 3(1), 1.

[15] Groome, M. J., Zell, E. R., Solomon, F., Nzenze, S., Parashar, U. D., Izu, A., & Madhi, S. A. (2016). Temporal association of rotavirus vaccine introduction and reduction in all-cause childhood diarrheal hospitalizations in South Africa. Clinical Infectious Diseases, 62(suppl_2), S188-S195.

[16] World Health Organization. (2017). Cholera vaccines: WHO position paper–August 2017. Weekly Epidemiological Record. 92(34), 477-498.

[17] Wierzba, T. F. (2018). Oral cholera vaccines and their impact on the global burden of disease. Human vaccines & immunotherapeutics, 1-8.

[18] Dimitrov, D. T., Troeger, C., Halloran, M. E., Longini, I. M., & Chao, D. L. (2014). Comparative effectiveness of different strategies of oral cholera vaccination in Bangladesh: a modeling study. PLoS neglected tropical diseases, 8(12), e3343.

>